Cached score snapshot

US.CAH · Cardinal Health

110分制 51.1/110；5D動能v2 4/50；排序分 55.1/160

Back to ranking Open volume snapshot

Ranking score 55.1/160

Main score 51.1/110

5D momentum v2 4/50

Rank #381

Setup grade F 24.3

Score breakdown

避免

Medium twelvedata

Score and price trend

F 24.3 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

**Historical projection**
Model	Median	P25/P75	歷史相似情境上漲比例	Down5	Actual / compare
Rolling DOE best · score 2.502 · anchors 120	+1.37%	-0.88% / +3.83%	64.4%	2%	Actual +2.85% · vs median +1.48% · inside 25-75 band
30D observation	+7.39%	+1.94% / +12.38%	81.4%	7.2%	Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160	+1.52%	-0.55% / +3.89%	66.3%	0.6%	Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-05-05 → 2026-09-10 · 264 archived points · 4 Improving turn signal · 4 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 55.1

Display grade 避免

Model version cursor_18_27_news_v2_160

Main score 51.1/110 (避免)

5D momentum v2 4/50 (弱)

Score with momentum v2 55.1/160 (低排序)

Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60

ma20 230.72

ma50 221.0988

close 227.19

prevClose 229.12

avgVolume20 2327727

volumeRatio 0.85

changePercent -0.84

Metrics snapshot

close 227.19

volume 1979949

changePercent -0.84

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 51.1/110

Main rating 避免

5D momentum v2 4/50

Score with momentum v2 55.1/160

Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 2.8/5 · 較差

Dimension score 2.8/5

Dimension grade 較差

Sub-items

pbPoints 0

pePoints 0.2

epsPoints 0.75

roePoints 0

debtPoints 0.5

marginPoints 0

turnoverUsdM 449.8246

volumePoints 0.5

revenuePoints 0

dividendPoints 0.3

marketCapPoints 0.5

資金流 — 9.2/20 · 較差

Dimension score 9.2/20

Dimension grade 較差

Sub-items

cmfPoints 0.8

mfiPoints 1.6

obvPoints 4

vwapPoints 0.8

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL

symbol US.CAH

message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.

optional true

holderCount n/a

holderPoints 2

top10ShareRatio n/a

concentrationPenalty 0

institutionPoints 2

市場環境 — 6.4/15 · 較差

Dimension score 6.4/15

Dimension grade 較差

Sub-items

vix

score 1.8

details

source twelvedata+fred

vixClose 20.66

trend

score 0.8

details

qqq

ma20 702.249

ma50 715.3588

name QQQ

close 683.55

points 0.4

spy

ma20 745.582

ma50 744.724

name SPY

close 741.69

points 0.4

source twelvedata+fred

atrPct 2.1838

atrPoints 3

cciPoints 0.8

vixPoints 1.8

marketTrendPoints 0.8

催化劑 — 2/20 · 較差

Dimension score 2/20

Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model

articleCount 8

catalystCount 0

catalystPoints 2

風險管理 — 7.4/10 · 良好

Dimension score 7.4/10

Dimension grade 良好

Sub-items

position

score 1.6

details

atrPct 2.1838

turnoverUsdM 449.8246

liquidityPoints 0.6

volatilityPoints 1

rrPoints 1.4

stopLevels

symbol US.CAH

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 217.2672

strength_details

ma_score 1.5

atr_score 2

rsi_score 2.5

macd_score 1.5

volume_score 1

market_adjustment 1

risk_reward_ratio 1.1

stop_loss_percent 4.4

take_profit_price 238.5495

target_multiplier 1.9

technical_strength 1.68

take_profit_percent 5

positionPoints 1.6

stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 4.3676

diversificationPoints 2

技術信號 — 17.3/30 · 較差

Dimension score 17.3/30

Dimension grade 較差

Sub-items

bbPoints 2.4

adxPoints 3

sarPoints 2.4

vcpPoints 0.4

macdPoints 2.4

vcpPayload

vcp_pass false

vcp_score 0.4

vcp_reason 站上MA50；Ready=N；Confirm=N

vcp_metrics

up_days 5

vol_ref 2402283.3333

down_days 4

vcp_ready false

above_ma50 true

avg_vol_10 2029770

avg_vol_20 2297215

avg_vol_30 2402283.3333

range_pct_10 0.0601

range_pct_20 0.1005

range_pct_30 0.1045

up_expand_ok false

lookback_used 59

near_20d_high true

contraction_ok false

down_shrink_ok false

up_expand_days 1

breakout_20d_ok false

vol_ratio_10_30 0.8449

dist_to_20d_high 0.0659

down_shrink_days 2

breakout_level_20d 243.21

vcp_breakout_confirm false

contraction_ratio_10_30 0.575

vcp_name_en Volatility Contraction Pattern

vcp_name_zh 波動收縮形態

vol_contraction false

kdjAdxPoints 0.7

rsiKdjPoints 1.6

volumeWeight 2

maCrossPoints 1.6

shortRsiPoints 1

shortMacdPoints 0.4

volConfirmPoints 0.6

volumePointsTechnical 0.8

情緒分析 — 6/10 · 一般

Dimension score 6/10

Dimension grade 一般

Sub-items

sentiment

score 6

details

source finnhub_news_keyword_model

articleCount 8

negativeHits 0

positiveHits 4

sentimentScoreRaw 1.2

sentimentData

raw {"id":141068498,"url":"https://finnhub.io/api/news?id=48e3395d5162853a725e1c4f5957cbbb031e9d2638d0c2bfbe96fe2b5900fdab","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.","category":"company","datetime":1785429901,"headline":"Here is Why Growth Investors Should Buy Cardinal (CAH) Now"}, {"id":141052229,"url":"https://finnhub.io/api/news?id=3090c6301c3ee96ed918bfbb98ce2e45e50fe40fb8be223dfc6849dbdd87cc71","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal Health stock has delivered a very strong 334.8% return over the past five years, yet its current checks lean expensive and suggest the recent share price strength may not leave much room for valuation comfort. Over 5 years, Cardinal Health has returned 334.8%, which puts extra focus on whether today's price still reflects a reasonable long term entry point. The push into home based care through the planned Strive Medical and AdaptHealth diabetes acquisitions can support growth...","category":"company","datetime":1785323402,"headline":"Cardinal Health (CAH) Stock Looks Pricey Following Its Home Care Deal Push"}, {"id":141048390,"url":"https://finnhub.io/api/news?id=f5f0bcde0488f910f4e4cf84a8af63b315414d2f91ee86c3fa038f0a1cb41e66","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"In the most recent trading session, Cardinal Health (CAH) closed at $232.51, indicating a +1.38% shift from the previous trading day.","category":"company","datetime":1785276004,"headline":"Why Cardinal Health (CAH) Outpaced the Stock Market Today"}, {"id":141003274,"url":"https://finnhub.io/api/news?id=b6399435ea83b76f1dff5f39ca28b0dde0b387998a31199e413f65395ebe7d52","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Earlier this week, Cardinal Health announced agreements to acquire AdaptHealth's Diabetes Health business and Strive Medical for about US$360 million in cash, aiming to expand its at-Home Solutions footprint in diabetes management and urology. These moves, combined with management’s previously raised profit guidance and a history of earnings outperformance, highlight Cardinal Health’s push to deepen its role in home-based care while emphasizing cost efficiency. Now we’ll examine how Cardinal...","category":"company","datetime":1784877435,"headline":"Do Cardinal Health’s New Home-Health Deals Reshape the Bull Case for CAH?"}, {"id":140983283,"url":"https://finnhub.io/api/news?id=7eef2f0ef94a310b7162f7e55cd6c983fa6afdabc8f241d4a68361586063a7be","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.","category":"company","datetime":1784727604,"headline":"Should Value Investors Buy Cardinal Health (CAH) Stock?"}, {"id":140978874,"url":"https://finnhub.io/api/news?id=783a5049009416e464f1383e47e60174f6f4857d26efb6e5b36639e3bd66769f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal Health is back in focus as analysts adjust their price targets, with some raising expectations into the mid US$260s to mid US$270s and others trimming targets by single or double digit amounts. These shifts are tied to refreshed earnings models on the bullish side and more cautious views on earnings and margin assumptions on the bearish side, leaving a wide range of opinions on how the stock should be valued. Read on to see how to interpret these changing targets and keep up with the...","category":"company","datetime":1784690373,"headline":"Cardinal Health (CAH) Stock Draws Fresh Price Target Split After Analyst Revisions"}, {"id":140966299,"url":"https://finnhub.io/api/news?id=01d27d6c081eae89d09fc7f0851542d156690188ad124e2161d8c9fa08a6f84e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal Health (CAH) reached $225.75 at the closing of the latest trading day, reflecting a -1.21% change compared to its last close.","category":"company","datetime":1784584803,"headline":"Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note"}, {"id":140905328,"url":"https://finnhub.io/api/news?id=1498bdd648988741dec00616509e87d01f6f00131e3d3d26db699d8e7350d89c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal Health’s recent performance and growth drivers Cardinal Health (CAH) has attracted fresh attention after entering the second half of 2026 with momentum tied to broad pharmaceutical demand and faster growth in its specialty businesses. For investors, the key question is how durable these drivers might prove. Specialty pharmaceuticals sit at the center of this story, with Cardinal Health benefiting from demand for oncology therapies, GLP-1 products, and branded medicines. Recent...","category":"company","datetime":1784081397,"headline":"Is Cardinal Health (CAH) Still Undervalued As Specialty Growth Lifts Expectations?"}

raw_source {"id":141069852,"url":"https://finnhub.io/api/news?id=386a60c4175b7abbbd17001351c4bf87e46acc6e1264303741f9877b999c3b4a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"CRL is set to report Q2 results on Aug. 5 as investors watch segment demand, divestitures, and whether the company can extend its earnings beat streak.","category":"company","datetime":1785432540,"headline":"Charles River Prepares to Report Q2 Earnings: What's in Store?"}, {"id":141069866,"url":"https://finnhub.io/api/news?id=0dfe3261d572d799bd0afc21d1b7620e68822a55e077b34e774063c0083f6990","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"CNMD's Q2 earnings and revenues beat estimates, while margin growth and solid international sales support a higher 2026 EPS outlook.","category":"company","datetime":1785430140,"headline":"CONMED Q2 Earnings and Revenues Beat Estimates, Gross Margin Expands"}, {"id":141068410,"url":"https://finnhub.io/api/news?id=158f7b2c996c478551835b9450571218c59e03e29195ae6524c63f0ad04ffc1f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"AVTR tops Q2 earnings and revenue estimates as VWR returned to organic growth early, prompting higher 2026 revenues and earnings guidance.","category":"company","datetime":1785429960,"headline":"Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised"}, {"id":141068498,"url":"https://finnhub.io/api/news?id=48e3395d5162853a725e1c4f5957cbbb031e9d2638d0c2bfbe96fe2b5900fdab","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.","category":"company","datetime":1785429901,"headline":"Here is Why Growth Investors Should Buy Cardinal (CAH) Now"}, {"id":141068474,"url":"https://finnhub.io/api/news?id=0597a13729b6d9787ac42ddd83e5f452f49594e62235d6bb08b83ff253b36bb8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"RVTY heads into Q2 earnings with improving Life Sciences demand and resilient Diagnostics. Can stronger margins offset lingering headwinds?","category":"company","datetime":1785429600,"headline":"Revvity to Report Q2 Earnings: What's in Store for the Stock?"}, {"id":141068411,"url":"https://finnhub.io/api/news?id=0007ffe0216e700b6c8ed0b3e1049e7206b7730a714da3b4daae9f8b75ec010f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Baxter beats second-quarter earnings and revenue estimates, posts broad-based segment growth and raises its 2026 outlook despite margin pressure.","category":"company","datetime":1785427320,"headline":"BAX Stock Gains on Q2 Earnings & Sales Beat, Margins Contract"}, {"id":141068412,"url":"https://finnhub.io/api/news?id=cc292e3b8f12ff007275fcb1af654d34bc6fe0a8a71b1d867b4bfd95cdd330fc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"GKOS' Q2 loss narrows as revenues jump 50% on iDose TR and Epioxa growth, lifting its 2026 sales outlook and shares by 9.8%.","category":"company","datetime":1785426900,"headline":"Glaukos Q2 Earnings Beat Estimates on iDose TR Growth, Stock Up"}, {"id":141055862,"url":"https://finnhub.io/api/news?id=d2c593c9349957b3ca16152323c967c4417d3ab3f9db8797978f488a55bb6f6e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"GE HealthCare beats second-quarter estimates as revenues rise 5.7%, orders climb 11.1% and backlog hits a record $23.9 billion.","category":"company","datetime":1785339720,"headline":"GEHC Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market"}, {"id":141055863,"url":"https://finnhub.io/api/news?id=dc6b208f3d8cb61b19b3c297a8cc56c2951996a4af7af738c66e92cd98982229","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"DVA's IKC momentum, higher 2026 guidance and technology investments support growth, while reimbursement and payer-mix risks cloud the outlook.","category":"company","datetime":1785337380,"headline":"Here's Why You Should Retain DaVita Stock in Your Portfolio for Now"}, {"id":141052957,"url":"https://finnhub.io/api/news?id=29f92a30df8ade7e656249e4e4a9b585c76fc2f81dc0788a86ee7f8f3e134c8e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Freehand's AI Agents autonomously manage supply-chain spend for Meta, Unilever, Johnson & Johnson, Dunkin', Pfizer and Cardinal Health. Freehand's AI Agents autonomously manage supply-chain spend for Meta, Unilever, Johnson & Johnson, Dunkin', Pfizer and Cardinal Health among others. Freehand builds autonomous AI agents that run supply-chain spend for the world's largest enterprises — taking on procurement, supplier management, invoice and payment operations across complex categories such as log","category":"company","datetime":1785330000,"headline":"Freehand Raises $75M to Scale AI Teams Managing Supply Chain Spend for Fortune 500 Companies"}, {"id":141052229,"url":"https://finnhub.io/api/news?id=3090c6301c3ee96ed918bfbb98ce2e45e50fe40fb8be223dfc6849dbdd87cc71","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal Health stock has delivered a very strong 334.8% return over the past five years, yet its current checks lean expensive and suggest the recent share price strength may not leave much room for valuation comfort. Over 5 years, Cardinal Health has returned 334.8%, which puts extra focus on whether today's price still reflects a reasonable long term entry point. The push into home based care through the planned Strive Medical and AdaptHealth diabetes acquisitions can support growth...","category":"company","datetime":1785323402,"headline":"Cardinal Health (CAH) Stock Looks Pricey Following Its Home Care Deal Push"}, {"id":141049147,"url":"https://finnhub.io/api/news?id=847f022feb42bf4d47a784124e1326cc42350ccd7a0f939c17b8e3547748713d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 14.3% over the past six months while the S&P 500 was up 6.3%.","category":"company","datetime":1785285902,"headline":"1 Healthcare Stock to Keep an Eye On and 2 We Avoid"}, {"id":141048390,"url":"https://finnhub.io/api/news?id=f5f0bcde0488f910f4e4cf84a8af63b315414d2f91ee86c3fa038f0a1cb41e66","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"In the most recent trading session, Cardinal Health (CAH) closed at $232.51, indicating a +1.38% shift from the previous trading day.","category":"company","datetime":1785276004,"headline":"Why Cardinal Health (CAH) Outpaced the Stock Market Today"}, {"id":141046401,"url":"https://finnhub.io/api/news?id=32ad537cf749428c45d48370b3a6ea3ee5ef6bbb0ca881255ba5054d1decc3b0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"ECL stock rises pre-market after earnings and revenues beat estimates, as pricing, volume growth and core-business demand lift organic sales.","category":"company","datetime":1785257820,"headline":"Ecolab Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market"}, {"id":141046402,"url":"https://finnhub.io/api/news?id=6a65cd8bb4225e38749850240bc29db3c65aae000cf5cf660f47852c738148f4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"OPK beats Q2 estimates as pharmaceutical growth, Nicoya income and lower costs narrow losses and lift shares pre-market.","category":"company","datetime":1785257700,"headline":"OPKO Health Stock Up as Q2 Earnings & Revenues Beat Estimates"}, {"id":141041785,"url":"https://finnhub.io/api/news?id=05331852a7fabd0d89cd994e30b93d517cda0768c3cccd460d522c8400fc7c69","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"CVS, CAH, HUM and ACAD show favorable earnings indicators ahead of Q2 results as healthcare demand stays resilient despite margin pressures.","category":"company","datetime":1785229320,"headline":"The Zacks Analyst Blog Highlights CVS Health, Cardinal Health, Humana and ACADIA Pharmaceuticals"}, {"id":141035283,"url":"https://finnhub.io/api/news?id=c9a7eade8b87a571ebf279bc11fef15776dcd6b21517b45c5e1c1b8d631aee38","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"CI's Q2 earnings are likely to face pressure from fewer insured medical customers and a higher MCR despite expected revenue growth.","category":"company","datetime":1785169980,"headline":"Will Declining Medical Customers Affect Cigna's Q2 Earnings?"}, {"id":141035247,"url":"https://finnhub.io/api/news?id=3ce6310c5a7787015ebdff11b4a2487d30095a481eeaf725620e2ed8721805d5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"CVS, CAH, HUM and ACAD look ready for Q2 2026 earnings beats as growing demand for medical products and services continues to support performance.","category":"company","datetime":1785168180,"headline":"4 Medical Stocks With the Right Setup for Q2 Earnings Beats"}, {"id":141033957,"url":"https://finnhub.io/api/news?id=f9c77f2c7a2b30fa8a6e2c19700b09a28d1482789e3ac5a2c0c0cc32cff09d93","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"A steadily shrinking share count and a giant float owed to suppliers are handing owners a bigger slice of the drug distributor each year, even as drug-pricing worries hang over the stock.","category":"company","datetime":1785160469,"headline":"The Buyback Machine Hiding Behind Cardinal Health's Thin Margins"}, {"id":141033965,"url":"https://finnhub.io/api/news?id=5d7090a4fb695f255effb47da586d72dcf54b4a024ad6a80984d2819806eaa0c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"MiniMed expands Flex access to Medicare beneficiaries, widening availability of its app-controlled pump and automated insulin delivery technology.","category":"company","datetime":1785158640,"headline":"MMED Gets Medicare Coverage for Flex and Broadens Diabetes Care Access"}, {"id":141033952,"url":"https://finnhub.io/api/news?id=e1356cc922d24b2065e4fc35f5b4985c2626ea5c847c8e830a021f485c0ba596","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"SYK heads into Q2 with robotic surgery momentum, deferred revenue recovery and strong procedure demand as investors watch for earnings and margin trends.","category":"company","datetime":1785157260,"headline":"Stryker's Q2 Results Likely to Reflect Recovery of Q1 Deferred Orders"}, {"id":141034153,"url":"https://finnhub.io/api/news?id=532c7af3118765071404809a553b30f6930cf4ea41667acd78881b6672af0c67","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"DXCM's Q2 results may reflect strong G7 15 Day adoption, broader reimbursement, and expanding CGM demand as investors watch for continued double-digit revenue growth.","category":"company","datetime":1785157200,"headline":"DXCM Q2 Results Likely to Reflect Strong G7 & Reimbursement Expansion"}, {"id":141009489,"url":"https://finnhub.io/api/news?id=e8ead56a4735e9ffc71c3db2d320d99fe8efb6a9ee65c2fd5ac7ddfc1def6ef0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"ECL's Q2 results are likely to benefit from strong growth engines and pricing gains, but elevated input costs may test margins and earnings momentum.","category":"company","datetime":1784913360,"headline":"Ecolab Gears Up to Report Q2 Results: How to Play the Stock?"}, {"id":141008022,"url":"https://finnhub.io/api/news?id=11f0b2223c504f705e7758c211d6947530f534883151cb699142f88e69716261","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"GE HealthCare heads into Q2 earnings season with solid revenue drivers, but inflation and tariff costs may keep margins under pressure before an expected second-half recovery.","category":"company","datetime":1784906640,"headline":"Can GE HealthCare Sustain Growth in Q2 Amid Persistent Cost Headwinds?"}, {"id":141008023,"url":"https://finnhub.io/api/news?id=f8f30bf84e1e15f6f6e57395b4c780f642075ee558f77c259033ceff89883108","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"BAX's second-quarter results may reflect pressured earnings and sales as manufacturing inefficiencies, inflation, and product holds offset steady demand across segments.","category":"company","datetime":1784906460,"headline":"Will Baxter's Q2 Results Continue to Reflect Operational Headwinds?"}, {"id":141010295,"url":"https://finnhub.io/api/news?id=4a5f786f5c2a16aec9237fc743c0601fa9f8494b3bc8026f8e392545ae8eac1b","image":"","source":"Benzinga","related":"CAH","summary":"Citigroup analyst Daniel Grosslight maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $245 to $265.","category":"company","datetime":1784906415,"headline":"Citigroup Maintains Buy on Cardinal Health, Raises Price Target to $265"}, {"id":141007920,"url":"https://finnhub.io/api/news?id=87f8d85494584027365a3886769e86bfba2dbfdaab5bcc5ff6b64728ff179ba8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"COR's specialty expansion, supply-chain investments and international momentum support growth, though pricing, debt and regulation pose risks.","category":"company","datetime":1784905740,"headline":"Here's Why You Should Add Cencora Stock to Your Portfolio Now"}, {"id":141007921,"url":"https://finnhub.io/api/news?id=81d9e34fdfd7a95dd140c3b55594eacb4f418e518b7d324ee8d3ea4ef365f1e6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"RVTY's T-SPOT A201 targets a 2027 launch, promising high-throughput latent TB testing with greater lab efficiency and scalability.","category":"company","datetime":1784905500,"headline":"Revvity Develops High-Throughput T-SPOT.TB Platform for Clinical Labs"}, {"id":141006590,"url":"https://finnhub.io/api/news?id=b9d1dbac7b295758ca6240d77ce744fd68e68aaf1579f112a00365686f982e57","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"SOLV's innovation, cost savings and strong segment demand support growth, while raw material cost increases remain a key risk.","category":"company","datetime":1784901600,"headline":"Here's Why You Should Hold Solventum Stock in Your Portfolio for Now"}, {"id":141003274,"url":"https://finnhub.io/api/news?id=b6399435ea83b76f1dff5f39ca28b0dde0b387998a31199e413f65395ebe7d52","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Earlier this week, Cardinal Health announced agreements to acquire AdaptHealth's Diabetes Health business and Strive Medical for about US$360 million in cash, aiming to expand its at-Home Solutions footprint in diabetes management and urology. These moves, combined with management’s previously raised profit guidance and a history of earnings outperformance, highlight Cardinal Health’s push to deepen its role in home-based care while emphasizing cost efficiency. Now we’ll examine how Cardinal...","category":"company","datetime":1784877435,"headline":"Do Cardinal Health’s New Home-Health Deals Reshape the Bull Case for CAH?"}, {"id":140997834,"url":"https://finnhub.io/api/news?id=8b5562ccad08c40b36749e0aaa7782b3c5636767b2c337583a15476bb8c73561","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"WST tops Q2 earnings and revenue estimates, lifts its 2026 EPS outlook and sees shares surge as high-value products fuel strong growth.","category":"company","datetime":1784830080,"headline":"WST Stock Jumps on Q2 Earnings & Sales Beat, EPS View Up on HVP Growth"}, {"id":140997924,"url":"https://finnhub.io/api/news?id=c608774f8f6aaf6348c7b29c9bed00d94e9b347c5e5957dac96e10936ea0836d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"QDEL's strong portfolio, cost-saving progress and mixed first-quarter results support growth, though respiratory reliance remains a risk.","category":"company","datetime":1784827980,"headline":"Reasons to Add QuidelOrtho Stock in Your Portfolio for Now"}, {"id":140997925,"url":"https://finnhub.io/api/news?id=6bec2c14e0d73dedc4197d0c596b947fcead06678116ed6826e141f2ca4addf9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"SNN expands ASC Solutions with an integrated platform, analytics and partners to boost efficiency, growth and patient outcomes in outpatient care.","category":"company","datetime":1784827620,"headline":"Smith+Nephew Expands ASC Platform to Support Value-Based Care"}, {"id":140997926,"url":"https://finnhub.io/api/news?id=82f5bd3150e1e8a592860033e378ef16e3e71e49827df4657245156df2d5c779","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"UHS heads into Q2 with higher admissions and revenue growth expected, but rising labor and operating costs may limit earnings upside.","category":"company","datetime":1784825040,"headline":"Can Acute Care Strength Offset Universal Health's Rising Q2 Costs?"}, {"id":140997927,"url":"https://finnhub.io/api/news?id=68be10255c11549211d68a39b771f136b909b37f137f465234c6a8b5d1ac0697","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"OPKO Health's growth outlook rests on RAYALDEE, BioReference gains and partnerships, though losses and pipeline risks persist.","category":"company","datetime":1784823660,"headline":"Here's Why You Should Retain OPK Stock in Your Portfolio for Now"}, {"id":140997797,"url":"https://finnhub.io/api/news?id=3cbb38d923198032baed48e5d05dc6047f885315cb8b30cb7e2d44f8a571886d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"CNMD's FDA-expanded AirSeal indication adds da Vinci 5 hex cannula compatibility, supporting broader use across Intuitive Surgical's robotic systems.","category":"company","datetime":1784823060,"headline":"CONMED Expands AirSeal Robotic Solution for da Vinci 5 Hex Cannula"}, {"id":141010296,"url":"https://finnhub.io/api/news?id=3fd4f32ce46bcab2a288abc97891d3464988d9574bfe61b88378add672f99c6e","image":"","source":"Benzinga","related":"CAH","summary":"Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $235 to $240.","category":"company","datetime":1784813023,"headline":"Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $240"}, {"id":140993539,"url":"https://finnhub.io/api/news?id=d04390a2f5d1a2ac12c0498d11018ae4d58fdbbed2027ac4d48b1ecb9c06efa1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"West Pharmaceutical (WST) delivered earnings and revenue surprises of +13.94% and +4.24%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?","category":"company","datetime":1784805304,"headline":"West Pharmaceutical Services (WST) Q2 Earnings and Revenues Top Estimates"}, {"id":140994921,"url":"https://finnhub.io/api/news?id=a98e6b0a0eaf99c2b60a5a3d3bdf912507cdb74f26aaa3e063c13c21cc6fbd59","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal Health will release its fourth-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.","category":"company","datetime":1784799518,"headline":"Here's What to Expect From Cardinal Health's Next Earnings Report"}, {"id":140984919,"url":"https://finnhub.io/api/news?id=0441267e55f97ee798e15ff361d070bf1c8ed9dc01745bc7ba5ff30f934d5764","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"CAH is set to buy two home-care businesses for about $360 million, expanding diabetes and urology reach while targeting first-year EPS accretion.","category":"company","datetime":1784737140,"headline":"Cardinal Health Expands Home Care Business With Two Acquisitions"}, {"id":140984920,"url":"https://finnhub.io/api/news?id=baf18e37cd128514c37b8ec0c38c1918eac8f805b29c5b540d025957786c2803","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"RVTY's Signals for Startups gives early-stage biotechs scalable software and guided onboarding to streamline research and support future growth.","category":"company","datetime":1784732640,"headline":"Revvity to Launch Signals for Startups for Emerging Biotech Companies"}, {"id":140983283,"url":"https://finnhub.io/api/news?id=7eef2f0ef94a310b7162f7e55cd6c983fa6afdabc8f241d4a68361586063a7be","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.","category":"company","datetime":1784727604,"headline":"Should Value Investors Buy Cardinal Health (CAH) Stock?"}, {"id":140981112,"url":"https://finnhub.io/api/news?id=4fc8f7191cac2b2f3f86171e5b4ff55bdb0c15596d5d0c81db60975f79be44d6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.","category":"company","datetime":1784714787,"headline":"2 Unpopular Stocks That Deserve Some Love and 1 We Turn Down"}, {"id":140978874,"url":"https://finnhub.io/api/news?id=783a5049009416e464f1383e47e60174f6f4857d26efb6e5b36639e3bd66769f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal Health is back in focus as analysts adjust their price targets, with some raising expectations into the mid US$260s to mid US$270s and others trimming targets by single or double digit amounts. These shifts are tied to refreshed earnings models on the bullish side and more cautious views on earnings and margin assumptions on the bearish side, leaving a wide range of opinions on how the stock should be valued. Read on to see how to interpret these changing targets and keep up with the...","category":"company","datetime":1784690373,"headline":"Cardinal Health (CAH) Stock Draws Fresh Price Target Split After Analyst Revisions"}, {"id":140973537,"url":"https://finnhub.io/api/news?id=0c072517ceb7964c6344ce4c4a6e1db55f5d2833aaccb9fecbfa046579ea7778","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal’s acquisitions of Strive Medical and Adapt Health’s diabetes unit are collectively intended to support its at-home care business’s growth strategy.","category":"company","datetime":1784650549,"headline":"Cardinal Health makes acquisition duo worth $360m for home care business advance"}, {"id":140973538,"url":"https://finnhub.io/api/news?id=76af9a8bf8e2849af662800ca1b3cd05f6380ad54f3412b8ccb29b5da1d3e9e5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"THC's Q2 performance is likely to have witnessed lower patient days, but higher revenue per admission and Ambulatory Care growth could help offset the pressure.","category":"company","datetime":1784648640,"headline":"Will Lower Patient Days Affect Tenet Healthcare's Q2 Earnings?"}, {"id":140973539,"url":"https://finnhub.io/api/news?id=fc59b28a72e9fb67c5de58ff9b6deef6c4e9908ebb0d5136f53ed8bdb8d7d728","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"WST heads into Q2 earnings with expectations for revenue and EPS growth, backed by demand for biologics and GLP-1 components plus manufacturing gains.","category":"company","datetime":1784647920,"headline":"WST Likely to Beat Q2 Earnings Estimates: How to Play the Stock?"}, {"id":140971931,"url":"https://finnhub.io/api/news?id=893e8bb7b41a606d4a508201130b3480b11bfd298966a40792889fd1dd974627","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"GE HealthCare's MIM Anyware offers secure browser-based imaging access to streamline workflows, collaboration and clinical decision-making.","category":"company","datetime":1784645280,"headline":"GEHC Launches MIM Anyware for Secure Remote Imaging Collaboration"}, {"id":140971932,"url":"https://finnhub.io/api/news?id=9dc23add3d9ada15715d94fd16e1187e4c495068461106dad986a374174d4076","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"The company agreed to buy a diabetes health business and medical supplier Strive Medical to boost its growing in-home solutions unit.","category":"company","datetime":1784623612,"headline":"Cardinal inks 2 acquisitions in bid to expand at-home services"}, {"id":140966299,"url":"https://finnhub.io/api/news?id=01d27d6c081eae89d09fc7f0851542d156690188ad124e2161d8c9fa08a6f84e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal Health (CAH) reached $225.75 at the closing of the latest trading day, reflecting a -1.21% change compared to its last close.","category":"company","datetime":1784584803,"headline":"Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note"}, {"id":140965034,"url":"https://finnhub.io/api/news?id=6556a2f7a1f3daf093ea745b2d90be0bcb4bafc556ac6a47297c7ea4eaf8efa0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal Health (NYSE: CAH) announced today it has entered into two definitive agreements that accelerate its at-Home Solutions' growth strategy.","category":"company","datetime":1784580300,"headline":"Cardinal Health expands home care business with two tuck-in acquisitions"}, {"id":140965035,"url":"https://finnhub.io/api/news?id=8ed0d2ad28580fb26c63d8fe709fbdd6958c7659c07e591f560e1f43eb772b3e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"CONSHOHOCKEN, Pa., July 20, 2026--AdaptHealth Corp. (NASDAQ: AHCO) (\"AdaptHealth\" or the \"Company\"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that it is divesting its Diabetes Health business to Cardinal Health.","category":"company","datetime":1784579400,"headline":"AdaptHealth Corp. Enters into Definitive Agreement to Divest Diabetes Health Business to Cardinal Health"}, {"id":140964561,"url":"https://finnhub.io/api/news?id=83ee53e90ed8e0942706b81bbdbf93d7db62ef947ae5e72eb97caff81ae785b1","image":"","source":"Benzinga","related":"CAH","summary":"Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ:AHCO), and, in its entirety, Strive Medical, a multi-specialty supply provider with a focus on urology. Combined, the transactions","category":"company","datetime":1784566064,"headline":"Cardinal Health To Acquire The Diabetes Health Business Of Adapthealth And, In Its Entirety, Strive Medical For ~$360M In Cash"}, {"id":140964562,"url":"https://finnhub.io/api/news?id=15dcbc13b14b566fd710405edbb0e31ee1407a64b45f61607fb058eac689837d","image":"","source":"Benzinga","related":"CAH","summary":"Continues the Company's multi-year effort to focus its portfolio on its core sleep, respiratory, and supporting home medical equipment businessesSharpens strategic focus on businesses where the Company crosses the","category":"company","datetime":1784565116,"headline":"AdaptHealth Divests Diabetes Health Business To Cardinal Health For $235M In Cash"}, {"id":140962261,"url":"https://finnhub.io/api/news?id=d1491913f71bc313ab8a352ccc02b142e871292111d7c0dac9b0483f878506cd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"HCA faces Q2 earnings uncertainty as rising expenses and fewer outpatient surgeries may offset admission growth.","category":"company","datetime":1784563980,"headline":"Will Higher Expenses Impact HCA Healthcare's Q2 Earnings?"}, {"id":140964563,"url":"https://finnhub.io/api/news?id=ba152ef37361b35766e43d27f97daec5c52fc4174eff439a919d1f0d8e21b6d5","image":"","source":"Benzinga","related":"CAH","summary":"UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $260 to $274.","category":"company","datetime":1784558481,"headline":"UBS Maintains Buy on Cardinal Health, Raises Price Target to $274"}, {"id":140960847,"url":"https://finnhub.io/api/news?id=81a8003193de79a3dbfb4e8aa9044d29e2a2203770ac8a44b4e0a51c3b594d32","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"BLCO launches EyeGility in the United States, pairing preloaded enVista Aspire lenses with smoother handling, one-handed use and surgical flexibility.","category":"company","datetime":1784555640,"headline":"Bausch + Lomb Launches EyeGility Inserter for enVista IOLs in the U.S."}, {"id":140936423,"url":"https://finnhub.io/api/news?id=8ca875368ce28e82d6155decc4435d9497d091af67c722269c1c88289c31709c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"DOCS is ramping up AI across physician workflows and enterprise tools, but weak pharma ads and higher AI spending may test near-term growth.","category":"company","datetime":1784312520,"headline":"Reasons to Retain Doximity Stock in Your Portfolio for Now"}, {"id":140936382,"url":"https://finnhub.io/api/news?id=c26d40ae96cad9381ff95484e035c0a112d0fbb5f231d9ab1d18d1ffceb82dfc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"ISRG beats second-quarter earnings and revenue estimates, but shares fall after hours as procedure growth slows sequentially despite strong placements.","category":"company","datetime":1784312400,"headline":"ISRG Q2 Earnings Beat Estimates, Stock Falls on Slow Procedure Growth"}, {"id":140934568,"url":"https://finnhub.io/api/news?id=fcdbb1523ac61c565eff444a9974ae081ef0444ebc3b4e416bbf2d2d7408ab7e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"SYK launches Mako RPS, expanding into handheld robotics for total knee replacement and broadening access to robotic-assisted orthopedic procedures.","category":"company","datetime":1784302740,"headline":"Stryker Launches Mako RPS to Expand Robotic Knee Surgery Portfolio"}, {"id":140933172,"url":"https://finnhub.io/api/news?id=584d2c6e82fe4caccaa31dd276f5f01a46c4f00e0bf9305af59a41c44c6ee4d2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Inspire Medical's Inspire V rollout, broader approvals and clinical evidence support growth despite coding and reimbursement pressures.","category":"company","datetime":1784299800,"headline":"Here's Why You Should Retain INSP Stock in Your Portfolio for Now"}, {"id":140933173,"url":"https://finnhub.io/api/news?id=fcfa156e27e5810bf40de392501c5b6b2e61189ff1e10b7810bc19e884395769","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"MOH faces lower Marketplace revenues and membership ahead of Q2 results, while Medicaid and Medicare premium growth may offset some pressure.","category":"company","datetime":1784299440,"headline":"Will Declining Membership Affect Molina Healthcare's Q2 Earnings?"}, {"id":140933174,"url":"https://finnhub.io/api/news?id=38f4dc886f6f5743ddce9ccc18ddb6b253fbb91f98948f8770e782ace9535fed","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"GE HealthCare's shares rise about 4% after unveiling a $500M, 10-year alliance to deploy 1,300 technologies across Catholic Health.","category":"company","datetime":1784298360,"headline":"GEHC Stock Up on $500M Strategic Care Alliance With Catholic Health"}, {"id":140924596,"url":"https://finnhub.io/api/news?id=d24a77b7980551d08549763d7ae3cb2c3a4883b982bad7c58ab0cf036f848548","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cooper Companies' premium contact lenses, restructuring gains and product launches support growth despite regional and competitive headwinds.","category":"company","datetime":1784220840,"headline":"Reasons to Retain Cooper Companies Stock in Your Portfolio for Now"}, {"id":140922761,"url":"https://finnhub.io/api/news?id=5c8b91a10f59cacf4ca9e21f467d05259ae902f69ce878fc4970cd452cbb654f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Community Health heads into Q2 earnings with mixed operating trends as stronger occupancy meets lower admissions and a smaller hospital portfolio.","category":"company","datetime":1784220780,"headline":"Can Higher Occupancy Offset Lower Admissions in CYH's Q2 Earnings?"}, {"id":140922763,"url":"https://finnhub.io/api/news?id=dc4955263ecd30f9602dfc000f5bacd34f86464174631084d5e636d601f094f3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"DHR heads into Q2 earnings with bioprocessing and diagnostics strength, but rising costs and debt could pressure profitability.","category":"company","datetime":1784216760,"headline":"Danaher Gears Up to Post Q2 Earnings: Is a Beat in the Offing?"}, {"id":140922823,"url":"https://finnhub.io/api/news?id=f0358eb2ef38cfac55cb710d83ab902a12899b63ff195ca18087e10e8ab46459","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"SNN launches the LYNX COBLATION Laryngeal Wand, combining precise dissection, rapid debulking and hemostasis for airway procedures.","category":"company","datetime":1784216460,"headline":"Smith+Nephew Launches LYNX COBLATION Wand for ENT Airway Surgery"}, {"id":140921221,"url":"https://finnhub.io/api/news?id=04cbc645f2a607054a9a97c3eafb4c1331d516813e8454f214b2e67053e84ce3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 results despite data security risks.","category":"company","datetime":1784212500,"headline":"Reasons to Hold HealthEquity Stock in Your Portfolio for Now"}, {"id":140921222,"url":"https://finnhub.io/api/news?id=760e9c1c7d69df2359d6c692b681a4463b5c079b953e5eeac0dbaa9ba9811f44","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"GUTS' shares surge after Revita patients retain up to 84% of GLP-1-induced weight loss in a year, compared with 46% for sham patients.","category":"company","datetime":1784211180,"headline":"Fractyl Health Stock Up on Encouraging One-Year Revita Study Results"}, {"id":140911503,"url":"https://finnhub.io/api/news?id=908a23ff1f0b5b57234053413e27a0b4eb754eefe15823bc8c1f0f9ad0380c6f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"West Pharmaceutical is riding on strong HVP demand, GLP-1 growth and Annex 1 adoption, but can these tailwinds outweigh capacity and concentration risks?","category":"company","datetime":1784131560,"headline":"Reasons to Add West Pharmaceutical Stock to Your Portfolio Now"}, {"id":140909892,"url":"https://finnhub.io/api/news?id=4c0aee8ff9ef958a5fe5cc75e951d08aabf5abc02060b4cccaabe752b70a9a40","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"ANGO's Q4 FY26 revenues rise 8% as Med Tech surges, while its adjusted loss beats estimates and FY27 sales guidance tops consensus.","category":"company","datetime":1784125740,"headline":"AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands"}, {"id":140909893,"url":"https://finnhub.io/api/news?id=2bfd112b99c9ec3d18c09c29045b6009dd3dda4c7f8f478a9cb09ccd225bb69b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"NPCE's RNS adoption, referral growth and AI innovation support expansion, while IGE timing and investments may pressure near-term profits.","category":"company","datetime":1784125380,"headline":"Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now"}, {"id":140909894,"url":"https://finnhub.io/api/news?id=5f4a27d23414e1bdf4b2eb1d42435dc1bc39ac051ca7eab04eb773d42fc9a2b3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"VEEV's strong Q1, growing Vault CRM migrations and AI expansion support growth, though life sciences CRM market saturation poses risks.","category":"company","datetime":1784120640,"headline":"Reasons to Hold Veeva Systems Stock in Your Portfolio for Now"}, {"id":140909895,"url":"https://finnhub.io/api/news?id=46345a98de08da41fa031ab46e797686326f9cd0769b7b49d99546bed55b740d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"AVTR's shares jump nearly 7% as NuSil expands its HIV prevention partnership for a three-month dapivirine vaginal ring.","category":"company","datetime":1784120460,"headline":"Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership"}, {"id":140908375,"url":"https://finnhub.io/api/news?id=f4ed62597339749c83f097a34940712bf56323e909a7559924a9e9e18e26238e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"TMO readies for second-quarter 2026 earnings, with growth expected across key segments as bioproduction, clinical research and new launches support results.","category":"company","datetime":1784119560,"headline":"Thermo Fisher Set to Report Q2 Earnings: What's in the Cards?"}, {"id":140905328,"url":"https://finnhub.io/api/news?id=1498bdd648988741dec00616509e87d01f6f00131e3d3d26db699d8e7350d89c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal Health’s recent performance and growth drivers Cardinal Health (CAH) has attracted fresh attention after entering the second half of 2026 with momentum tied to broad pharmaceutical demand and faster growth in its specialty businesses. For investors, the key question is how durable these drivers might prove. Specialty pharmaceuticals sit at the center of this story, with Cardinal Health benefiting from demand for oncology therapies, GLP-1 products, and branded medicines. Recent...","category":"company","datetime":1784081397,"headline":"Is Cardinal Health (CAH) Still Undervalued As Specialty Growth Lifts Expectations?"}, {"id":140904333,"url":"https://finnhub.io/api/news?id=0b64755bd48b71f6c1a8155c9a0f7dba2208fe96790993d8d7e183c57505fef8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"In the closing of the recent trading day, Cardinal Health (CAH) stood at $230.11, denoting a -1.52% move from the preceding trading day.","category":"company","datetime":1784066402,"headline":"Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why"}, {"id":140898373,"url":"https://finnhub.io/api/news?id=7f5bdde751f9c35aa6159ecbf69ebd1e7c98ab35526de50e323e5694daee49eb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"DexCom's G7 15 Day wins Health Canada authorization, offering longer wear, high accuracy and smart features for adults with diabetes.","category":"company","datetime":1784038800,"headline":"DXCM Secures Health Canada Authorization for Dexcom G7 15 Day CGM"}, {"id":140897140,"url":"https://finnhub.io/api/news?id=17b1a1c2cd8f1e4d82fd54c4e45c19b1481a4408b625cd8b02959bdf27ace66c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal Health stock has delivered a very strong 5 year run, yet the current valuation checks lean expensive, which raises the question of how much of that strength is already reflected in the price. The share price has returned about 365.1% over 5 years, which places recent gains in the context of a long period of strong compounding. Recent news highlights growth momentum in higher margin specialty pharmaceuticals and chronic care, while competitive and regulatory pressures remain an...","category":"company","datetime":1784035219,"headline":"Cardinal Health (CAH) Stock Looks Overvalued Following Fresh Earnings Beat Hopes"}, {"id":140895339,"url":"https://finnhub.io/api/news?id=c1c02517fb2d6062636fc20fa28984d3617d173e198049742585adea5db0ca27","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outlook article.","category":"company","datetime":1784014260,"headline":"Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry"}, {"id":140890118,"url":"https://finnhub.io/api/news?id=2d67f1cbe12d9df8211cfc8bae473d12b523f08edb98312468848a3f2b0237d7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"ELV faces Q2 pressure as weaker Health Benefits results and higher benefit expenses may weigh on earnings ahead of its July 15 report.","category":"company","datetime":1783966080,"headline":"Will Health Benefits Weakness Drag Elevance's Q2 Earnings?"}, {"id":140888586,"url":"https://finnhub.io/api/news?id=02c32f4236530d9c3c8408db3b26474a8bed1445de7e9b3af2fa2a9fcebd5ba0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.","category":"company","datetime":1783961101,"headline":"Looking for a Growth Stock? 3 Reasons Why Cardinal (CAH) is a Solid Choice"}, {"id":140888587,"url":"https://finnhub.io/api/news?id=23fd34574599028cd6535e7a4f359605d176c869633009b46055b092da4d12f5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Here, we highlight five dental supplies stocks, MCK, CAH, WST, ALGN and HSIC, which are well positioned to generate wealth for investors amid improving industry prospect.","category":"company","datetime":1783960560,"headline":"5 Medical Supply Stocks to Buy Amid Strong Industry Tailwinds"}, {"id":140888588,"url":"https://finnhub.io/api/news?id=6b1d5a7ae5e4207e8a8614cd2954d3fa23c977d91e49e1e4a198995ffbf0ba43","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.","category":"company","datetime":1783959003,"headline":"Why Cardinal (CAH) is Poised to Beat Earnings Estimates Again"}, {"id":140887112,"url":"https://finnhub.io/api/news?id=0f04adeb023c5b19c5040c5712ccad327b737146e55e34c0fd0eb52164c77616","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Here is how argenex SE (ARGX) and Cardinal Health (CAH) have performed compared to their sector so far this year.","category":"company","datetime":1783950004,"headline":"Are Medical Stocks Lagging Argenx (ARGX) This Year?"}, {"id":140866137,"url":"https://finnhub.io/api/news?id=3f13457ebf4a4219407fc1e247b73e139d9eff63c7d44cc4326643ba6b21d03b","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"CAH","summary":"A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the latest list here.","category":"company","datetime":1783706132,"headline":"Dividend Champion, Contender, And Challenger Highlights: Week Of July 12"}, {"id":140863166,"url":"https://finnhub.io/api/news?id=e946794061ef07309da8a11ae69a8862df0fff20c00259ff44cede14df1fa8a2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"The average brokerage recommendation (ABR) for Cardinal (CAH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?","category":"company","datetime":1783690203,"headline":"Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest?"}, {"id":140854823,"url":"https://finnhub.io/api/news?id=458be9d1a0c21e9ffb0379eda2cd0d33d1c708842673ec4aae2c1304cd927346","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"CAH's Russell index removal reflects reclassification after its share rally, while specialty growth and resilient operations continue supporting its long-term outlook.","category":"company","datetime":1783621260,"headline":"Should You Retain CAH Stock After Removal From Several Russell Indices?"}, {"id":140851015,"url":"https://finnhub.io/api/news?id=80cb5ec78359f04f857bbd8be1ca3f1da0e6c2e01ae8595ae0acef02466d10d9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"While the market debates growth, this healthcare giant is steadily retiring its own shares, a strategy that has quietly compounded value for investors.","category":"company","datetime":1783603475,"headline":"McKesson Stock Is Shrinking, and That's The Point for Owners"}, {"id":140853648,"url":"https://finnhub.io/api/news?id=b2d05548698b403d1523232e7d03e840810070ba29e7cfbb57b5b9e02c77c856","image":"","source":"Benzinga","related":"CAH","summary":"TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $255 to $275.","category":"company","datetime":1783599877,"headline":"TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $275"}, {"id":140850071,"url":"https://finnhub.io/api/news?id=de200de5ce1b21a0426a5352101b175508fdd6c749c77d1606f6c11f30c60029","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2026 on August 11, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.","category":"company","datetime":1783593900,"headline":"Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2026 on August 11"}, {"id":140846416,"url":"https://finnhub.io/api/news?id=4d1ac8d3b07142e4e7e2fd6ddf2a31d3ec0e9057b634a2c9561f03335dac0dec","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal Health (CAH) concluded the recent trading session at $237.15, signifying a -1.07% move from its prior day's close.","category":"company","datetime":1783548903,"headline":"Cardinal Health (CAH) Declines More Than Market: Some Information for Investors"}, {"id":140844540,"url":"https://finnhub.io/api/news?id=461ed182f4f549cdfa263d6a928aea7f3d04659f55a2bb0153bb938bd4603612","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"While the market debates the future of drug pricing, this healthcare giant is steadily handing a larger piece of the business back to its owners.","category":"company","datetime":1783535061,"headline":"McKesson Stock Is Shrinking, And That's The Point"}, {"id":140842566,"url":"https://finnhub.io/api/news?id=0302ac2b2ac358fb031e0e7752080a8d220ecc3485e7bb3c6c0fd7cee8712075","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2227733246/image_2227733246.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"CAH","summary":"McKesson is a stable portfolio holding with regular moderate growth amid a challenging, overvalued market environment. Read more on MCK stock here.","category":"company","datetime":1783516359,"headline":"McKesson Checks All The Boxes To Survive And Prosper In A Weak Economy, But There's A Big Catch"}, {"id":140835507,"url":"https://finnhub.io/api/news?id=1ff4aac3f9d633edc4fe2b43d1c25618d747701c819628733167f2c6c3ec7211","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"In late June 2026, Cardinal Health, Inc. was removed from the Russell 1000 Defensive, Russell 1000 Growth-Defensive, and Russell 1000 Value-Defensive indices, even as it reported quarterly revenue of US$60.94 billion and net profit of US$399 million. At the same time, upbeat commentary from Jim Cramer and reaffirmed positive analyst views highlighted Cardinal Health’s reputation as a healthcare sector stalwart despite its index reclassifications. Next, we’ll examine how this combination of...","category":"company","datetime":1783459063,"headline":"Does Index Removal Amid Solid Results Change The Bull Case For Cardinal Health (CAH)?"}, {"id":140842604,"url":"https://finnhub.io/api/news?id=25b9737c32659b118e6d06e5fd552407615007fb05e58b3082830c3625d38b4e","image":"https://image.cnbcfm.com/api/v1/image/108331765-3ED1-MM-A-070726.jpg?v=1783463497&w=1920&h=1080","source":"CNBC","related":"CAH","summary":"CNBC's Jim Cramer discusses the day's market action, the stocks he's watching and more.","category":"company","datetime":1783451536,"headline":"I find it surprising that so much money was flowing into the hyperscalers: Cramer"}, {"id":140822441,"url":"https://finnhub.io/api/news?id=a8a1b28066f6e208b8e9c7195cc557e003be78ce757401f35ac4df52844cd88e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.","category":"company","datetime":1783358941,"headline":"Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?"}, {"id":140807781,"url":"https://finnhub.io/api/news?id=7d52d19d05cda671822fdd3b1227333a17707b003b922bd120c0f38bcdee2052","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Cardinal Health, Inc. (NYSE:CAH) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer said that the stock deserves to “trade higher,” as he commented: Can I call your attention to what may be the best one in this group? I’m talking about […]","category":"company","datetime":1783174848,"headline":"Jim Cramer on Cardinal Health: “It’s Been a Real Stalwart, and I Don’t Think It’s Done”"}, {"id":140801970,"url":"https://finnhub.io/api/news?id=8d6fb7d50212e52acef49fd4cca54e09d0c6c76b24dd5b4a0917e964b5baf046","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1886168190/image_1886168190.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"CAH","summary":"Cardinal Health receives a Buy rating, supported by defensive business fundamentals and strong adjusted EPS growth. Read more on CAH stock here.","category":"company","datetime":1783090514,"headline":"Cardinal Health: Why This Essential Healthcare Distributor Deserves A Buy Rating"}, {"id":140793341,"url":"https://finnhub.io/api/news?id=7751c4204569198b12c51f40c3f0ddd3f71d55fcc2e968637c26a0615101294c","image":"","source":"Benzinga","related":"CAH","summary":"B of A Securities analyst Allen Lutz maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $240 to $260.","category":"company","datetime":1782990015,"headline":"B of A Securities Maintains Buy on Cardinal Health, Raises Price Target to $260"}, {"id":140792257,"url":"https://finnhub.io/api/news?id=c695286d7754a1888990f708cd63bc406a376127bc2185825e118715ea2c95c2","image":"https://image.cnbcfm.com/api/v1/image/108329650-4ED3-MM-A-BLOCK-070126.jpg?v=1782947054&w=1920&h=1080","source":"CNBC","related":"CAH","summary":"CNBC's Jim Cramer discusses the day's market action, the stocks he's watching and more.","category":"company","datetime":1782933515,"headline":"Meta's new cloud business will be instantly profitable, says Jim Cramer"}, {"id":140780871,"url":"https://finnhub.io/api/news?id=af5080e11481be0b1b046a88ccbc555298fda3756f3f9b31ba119c574a829518","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"CAH","summary":"Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.","category":"company","datetime":1782913203,"headline":"Are Investors Undervaluing Cardinal Health (CAH) Right Now?"}

data_source finnhub_news_keyword_model

article_count 8

negative_hits 0

positive_hits 4

recomputed_at_score true

sentiment_score_raw 1.2

source_article_count 102

discarded_article_count 85

sentimentPoints 6

Dimension contribution

Dimension Raw Max Norm % Contrib

基本面 2.8 5/110 56% 2.8

資金流 9.2 20/110 46% 9.2

市場環境 6.4 15/110 42.67% 6.4

催化劑 2 20/110 10% 2

風險管理 7.4 10/110 74% 7.4

技術信號 17.3 30/110 57.67% 17.3

情緒分析 6 10/110 60% 6

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 4/50

ret_5d 0.0054

max_score 50

max_total 50

raw_total 4

vcp_bonus 0

vol_ratio 0.8619

ret_points 4

vol_points 0

range_ratio 0.734

volat_points 0

day_range_pct 0.0162

model_version cursor_18_27_news_v2_160

available_bars 30

breakout_points 0

partial_history false

pullback_points 0

breakout_vol_bonus 0

first_breakout_20d false

return_window_days 5

first_breakout_bonus 0

breakout_quality_points 0

Risk management

level Medium

reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 2.1838

turnoverUsdM 449.8246

liquidityPoints 0.6

volatilityPoints 1

rrPoints 1.4

stopLevels

symbol US.CAH

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 217.2672

strength_details

ma_score 1.5

atr_score 2

rsi_score 2.5

macd_score 1.5

volume_score 1

market_adjustment 1

risk_reward_ratio 1.1

stop_loss_percent 4.4

take_profit_price 238.5495

target_multiplier 1.9

technical_strength 1.68

take_profit_percent 5

positionPoints 1.6

stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 4.3676

diversificationPoints 2

Calculation audit log

基本面分析總分: 2.8/5分
資金流分析總分: 9.2/20分
市場環境分析總分: 6.4/15分
催化劑分析: 2/20分
風險管理總分: 7.4/10分
技術信號分析總分: 17.3/30分
情緒分析: 6/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx

value 92.86

atr

atr 4.9614

rule ATR / current price; lower volatility scores higher

score 6

atr_pct 2.18

cci

rule Cursor_18.24 CCI bands

level 超買或超賣風險

score 2

value -70.58

cmf

rule Cursor_18.24 CMF bands

level 派發

score 2

value -0.147

kdj

d 51.63

j 70.46

k 57.91

rule Cursor_18.24 K/D cross

score 4

signal 金叉

mfi

rule Cursor_18.24 MFI bands

level 弱流入

score 4

value 46.85

obv

rule Cursor_18.24 recent_slope vs previous_slope

score 10

trend 強流入

value 19394751

recentSlope -30124.9

previousSlope -952480

rsi

value 39.94

sar

rule Cursor_18.24 Parabolic SAR

score 8

trend 上升

value 221.1733

position SAR喺價下

distancePct 2.65

previousTrend 上升

ma50

value 221.0988

macd

macd 1.1408

trend 中性偏多

signal 2.0679

histogram -0.927

vwap

rule Cursor_18.24 VWAP 20D consecutive close

score 2

value 231.6401

position <VWAP

consecutiveAbove 0

volume

rule Cursor_18.24 volume ratio

level 無力

ratio 0.85

score 4

avgVolume 2327727

currentVolume 1979949

derived

ma20 230.72

ma50 221.0988

prevClose 229.12

avgVolume10 1966985

avgVolume20 2327727

changePercent -0.84

avgVolumeForScore 2327727

ma_cross

ma20 230.72

ma50 221.0988

rule Cursor_18.24 MA20/MA50 cross

cross 多頭

score 4

prevMa20 231.2465

prevMa50 220.5504

spreadPct 4.35

isVolumeBreakout false

bollinger

lower 220.5843

upper 240.8557

position 中間

rsi_short

value 69.23

macd_short

macd 0

trend 中性

signal 0

histogram 0

volume_ratio

ratio 0.85

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.18381090717021,
        "turnoverUsdM": 449.82461331,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.CAH",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 217.2672,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 2.5,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 4.4,
      "take_profit_price": 238.5495,
      "target_multiplier": 1.9,
      "technical_strength": 1.68,
      "take_profit_percent": 5
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.36762181434042,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 55.1,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 51.1,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 4
  },
  "market": {
    "ma20": 230.72,
    "ma50": 221.0988,
    "close": 227.19,
    "prevClose": 229.12,
    "avgVolume20": 2327727,
    "volumeRatio": 0.85,
    "changePercent": -0.84
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 4,
    "details": {
      "ret_5d": 0.005354456146561715,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 4,
      "vcp_bonus": 0,
      "vol_ratio": 0.8618910289198007,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 0.7340327206418518,
      "volat_points": 0,
      "day_range_pct": 0.016153880012324432,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 0,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 55.1,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.8,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 56,
        "contribution": 2.8
      },
      {
        "raw": 9.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 46,
        "contribution": 9.2
      },
      {
        "raw": 6.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 42.67,
        "contribution": 6.4
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 17.3,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 57.67,
        "contribution": 17.3
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 51.1,
    "details": [
      "基本面分析總分: 2.8/5分",
      "資金流分析總分: 9.2/20分",
      "市場環境分析總分: 6.4/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 17.3/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.8,
      "資金流": 9.2,
      "市場環境": 6.4,
      "情緒分析": 6,
      "技術信號": 17.3,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0,
          "pePoints": 0.2,
          "epsPoints": 0.75,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 449.82461331,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 1.6,
          "obvPoints": 4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.CAH",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 20.66
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 702.2489964000001,
                "ma50": 715.3588015999999,
                "name": "QQQ",
                "close": 683.54999,
                "points": 0.4
              },
              "spy": {
                "ma20": 745.5820062000001,
                "ma50": 744.7240025799999,
                "name": "SPY",
                "close": 741.69,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.18381090717021,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 1.8,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 4,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141068498,
                "url": "https://finnhub.io/api/news?id=48e3395d5162853a725e1c4f5957cbbb031e9d2638d0c2bfbe96fe2b5900fdab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.",
                "category": "company",
                "datetime": 1785429901,
                "headline": "Here is Why Growth Investors Should Buy Cardinal (CAH) Now"
              },
              {
                "id": 141052229,
                "url": "https://finnhub.io/api/news?id=3090c6301c3ee96ed918bfbb98ce2e45e50fe40fb8be223dfc6849dbdd87cc71",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health stock has delivered a very strong 334.8% return over the past five years, yet its current checks lean expensive and suggest the recent share price strength may not leave much room for valuation comfort. Over 5 years, Cardinal Health has returned 334.8%, which puts extra focus on whether today's price still reflects a reasonable long term entry point. The push into home based care through the planned Strive Medical and AdaptHealth diabetes acquisitions can support growth...",
                "category": "company",
                "datetime": 1785323402,
                "headline": "Cardinal Health (CAH) Stock Looks Pricey Following Its Home Care Deal Push"
              },
              {
                "id": 141048390,
                "url": "https://finnhub.io/api/news?id=f5f0bcde0488f910f4e4cf84a8af63b315414d2f91ee86c3fa038f0a1cb41e66",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In the most recent trading session, Cardinal Health (CAH) closed at $232.51, indicating a +1.38% shift from the previous trading day.",
                "category": "company",
                "datetime": 1785276004,
                "headline": "Why Cardinal Health (CAH) Outpaced the Stock Market Today"
              },
              {
                "id": 141003274,
                "url": "https://finnhub.io/api/news?id=b6399435ea83b76f1dff5f39ca28b0dde0b387998a31199e413f65395ebe7d52",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Earlier this week, Cardinal Health announced agreements to acquire AdaptHealth's Diabetes Health business and Strive Medical for about US$360 million in cash, aiming to expand its at-Home Solutions footprint in diabetes management and urology. These moves, combined with management’s previously raised profit guidance and a history of earnings outperformance, highlight Cardinal Health’s push to deepen its role in home-based care while emphasizing cost efficiency. Now we’ll examine how Cardinal...",
                "category": "company",
                "datetime": 1784877435,
                "headline": "Do Cardinal Health’s New Home-Health Deals Reshape the Bull Case for CAH?"
              },
              {
                "id": 140983283,
                "url": "https://finnhub.io/api/news?id=7eef2f0ef94a310b7162f7e55cd6c983fa6afdabc8f241d4a68361586063a7be",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
                "category": "company",
                "datetime": 1784727604,
                "headline": "Should Value Investors Buy Cardinal Health (CAH) Stock?"
              },
              {
                "id": 140978874,
                "url": "https://finnhub.io/api/news?id=783a5049009416e464f1383e47e60174f6f4857d26efb6e5b36639e3bd66769f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health is back in focus as analysts adjust their price targets, with some raising expectations into the mid US$260s to mid US$270s and others trimming targets by single or double digit amounts. These shifts are tied to refreshed earnings models on the bullish side and more cautious views on earnings and margin assumptions on the bearish side, leaving a wide range of opinions on how the stock should be valued. Read on to see how to interpret these changing targets and keep up with the...",
                "category": "company",
                "datetime": 1784690373,
                "headline": "Cardinal Health (CAH) Stock Draws Fresh Price Target Split After Analyst Revisions"
              },
              {
                "id": 140966299,
                "url": "https://finnhub.io/api/news?id=01d27d6c081eae89d09fc7f0851542d156690188ad124e2161d8c9fa08a6f84e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) reached $225.75 at the closing of the latest trading day, reflecting a -1.21% change compared to its last close.",
                "category": "company",
                "datetime": 1784584803,
                "headline": "Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note"
              },
              {
                "id": 140905328,
                "url": "https://finnhub.io/api/news?id=1498bdd648988741dec00616509e87d01f6f00131e3d3d26db699d8e7350d89c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health’s recent performance and growth drivers Cardinal Health (CAH) has attracted fresh attention after entering the second half of 2026 with momentum tied to broad pharmaceutical demand and faster growth in its specialty businesses. For investors, the key question is how durable these drivers might prove. Specialty pharmaceuticals sit at the center of this story, with Cardinal Health benefiting from demand for oncology therapies, GLP-1 products, and branded medicines. Recent...",
                "category": "company",
                "datetime": 1784081397,
                "headline": "Is Cardinal Health (CAH) Still Undervalued As Specialty Growth Lifts Expectations?"
              }
            ],
            "raw_source": [
              {
                "id": 141069852,
                "url": "https://finnhub.io/api/news?id=386a60c4175b7abbbd17001351c4bf87e46acc6e1264303741f9877b999c3b4a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CRL is set to report Q2 results on Aug. 5 as investors watch segment demand, divestitures, and whether the company can extend its earnings beat streak.",
                "category": "company",
                "datetime": 1785432540,
                "headline": "Charles River Prepares to Report Q2 Earnings: What's in Store?"
              },
              {
                "id": 141069866,
                "url": "https://finnhub.io/api/news?id=0dfe3261d572d799bd0afc21d1b7620e68822a55e077b34e774063c0083f6990",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CNMD's Q2 earnings and revenues beat estimates, while margin growth and solid international sales support a higher 2026 EPS outlook.",
                "category": "company",
                "datetime": 1785430140,
                "headline": "CONMED Q2 Earnings and Revenues Beat Estimates, Gross Margin Expands"
              },
              {
                "id": 141068410,
                "url": "https://finnhub.io/api/news?id=158f7b2c996c478551835b9450571218c59e03e29195ae6524c63f0ad04ffc1f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AVTR tops Q2 earnings and revenue estimates as VWR returned to organic growth early, prompting higher 2026 revenues and earnings guidance.",
                "category": "company",
                "datetime": 1785429960,
                "headline": "Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised"
              },
              {
                "id": 141068498,
                "url": "https://finnhub.io/api/news?id=48e3395d5162853a725e1c4f5957cbbb031e9d2638d0c2bfbe96fe2b5900fdab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.",
                "category": "company",
                "datetime": 1785429901,
                "headline": "Here is Why Growth Investors Should Buy Cardinal (CAH) Now"
              },
              {
                "id": 141068474,
                "url": "https://finnhub.io/api/news?id=0597a13729b6d9787ac42ddd83e5f452f49594e62235d6bb08b83ff253b36bb8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "RVTY heads into Q2 earnings with improving Life Sciences demand and resilient Diagnostics. Can stronger margins offset lingering headwinds?",
                "category": "company",
                "datetime": 1785429600,
                "headline": "Revvity to Report Q2 Earnings: What's in Store for the Stock?"
              },
              {
                "id": 141068411,
                "url": "https://finnhub.io/api/news?id=0007ffe0216e700b6c8ed0b3e1049e7206b7730a714da3b4daae9f8b75ec010f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Baxter beats second-quarter earnings and revenue estimates, posts broad-based segment growth and raises its 2026 outlook despite margin pressure.",
                "category": "company",
                "datetime": 1785427320,
                "headline": "BAX Stock Gains on Q2 Earnings & Sales Beat, Margins Contract"
              },
              {
                "id": 141068412,
                "url": "https://finnhub.io/api/news?id=cc292e3b8f12ff007275fcb1af654d34bc6fe0a8a71b1d867b4bfd95cdd330fc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "GKOS' Q2 loss narrows as revenues jump 50% on iDose TR and Epioxa growth, lifting its 2026 sales outlook and shares by 9.8%.",
                "category": "company",
                "datetime": 1785426900,
                "headline": "Glaukos Q2 Earnings Beat Estimates on iDose TR Growth, Stock Up"
              },
              {
                "id": 141055862,
                "url": "https://finnhub.io/api/news?id=d2c593c9349957b3ca16152323c967c4417d3ab3f9db8797978f488a55bb6f6e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "GE HealthCare beats second-quarter estimates as revenues rise 5.7%, orders climb 11.1% and backlog hits a record $23.9 billion.",
                "category": "company",
                "datetime": 1785339720,
                "headline": "GEHC Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market"
              },
              {
                "id": 141055863,
                "url": "https://finnhub.io/api/news?id=dc6b208f3d8cb61b19b3c297a8cc56c2951996a4af7af738c66e92cd98982229",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "DVA's IKC momentum, higher 2026 guidance and technology investments support growth, while reimbursement and payer-mix risks cloud the outlook.",
                "category": "company",
                "datetime": 1785337380,
                "headline": "Here's Why You Should Retain DaVita Stock in Your Portfolio for Now"
              },
              {
                "id": 141052957,
                "url": "https://finnhub.io/api/news?id=29f92a30df8ade7e656249e4e4a9b585c76fc2f81dc0788a86ee7f8f3e134c8e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Freehand's AI Agents autonomously manage supply-chain spend for Meta, Unilever, Johnson & Johnson, Dunkin', Pfizer and Cardinal Health. Freehand's AI Agents autonomously manage supply-chain spend for Meta, Unilever, Johnson & Johnson, Dunkin', Pfizer and Cardinal Health among others. Freehand builds autonomous AI agents that run supply-chain spend for the world's largest enterprises — taking on procurement, supplier management, invoice and payment operations across complex categories such as log",
                "category": "company",
                "datetime": 1785330000,
                "headline": "Freehand Raises $75M to Scale AI Teams Managing Supply Chain Spend for Fortune 500 Companies"
              },
              {
                "id": 141052229,
                "url": "https://finnhub.io/api/news?id=3090c6301c3ee96ed918bfbb98ce2e45e50fe40fb8be223dfc6849dbdd87cc71",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health stock has delivered a very strong 334.8% return over the past five years, yet its current checks lean expensive and suggest the recent share price strength may not leave much room for valuation comfort. Over 5 years, Cardinal Health has returned 334.8%, which puts extra focus on whether today's price still reflects a reasonable long term entry point. The push into home based care through the planned Strive Medical and AdaptHealth diabetes acquisitions can support growth...",
                "category": "company",
                "datetime": 1785323402,
                "headline": "Cardinal Health (CAH) Stock Looks Pricey Following Its Home Care Deal Push"
              },
              {
                "id": 141049147,
                "url": "https://finnhub.io/api/news?id=847f022feb42bf4d47a784124e1326cc42350ccd7a0f939c17b8e3547748713d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 14.3% over the past six months while the S&P 500 was up 6.3%.",
                "category": "company",
                "datetime": 1785285902,
                "headline": "1 Healthcare Stock to Keep an Eye On and 2 We Avoid"
              },
              {
                "id": 141048390,
                "url": "https://finnhub.io/api/news?id=f5f0bcde0488f910f4e4cf84a8af63b315414d2f91ee86c3fa038f0a1cb41e66",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In the most recent trading session, Cardinal Health (CAH) closed at $232.51, indicating a +1.38% shift from the previous trading day.",
                "category": "company",
                "datetime": 1785276004,
                "headline": "Why Cardinal Health (CAH) Outpaced the Stock Market Today"
              },
              {
                "id": 141046401,
                "url": "https://finnhub.io/api/news?id=32ad537cf749428c45d48370b3a6ea3ee5ef6bbb0ca881255ba5054d1decc3b0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "ECL stock rises pre-market after earnings and revenues beat estimates, as pricing, volume growth and core-business demand lift organic sales.",
                "category": "company",
                "datetime": 1785257820,
                "headline": "Ecolab Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market"
              },
              {
                "id": 141046402,
                "url": "https://finnhub.io/api/news?id=6a65cd8bb4225e38749850240bc29db3c65aae000cf5cf660f47852c738148f4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "OPK beats Q2 estimates as pharmaceutical growth, Nicoya income and lower costs narrow losses and lift shares pre-market.",
                "category": "company",
                "datetime": 1785257700,
                "headline": "OPKO Health Stock Up as Q2 Earnings & Revenues Beat Estimates"
              },
              {
                "id": 141041785,
                "url": "https://finnhub.io/api/news?id=05331852a7fabd0d89cd994e30b93d517cda0768c3cccd460d522c8400fc7c69",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS, CAH, HUM and ACAD show favorable earnings indicators ahead of Q2 results as healthcare demand stays resilient despite margin pressures.",
                "category": "company",
                "datetime": 1785229320,
                "headline": "The Zacks Analyst Blog Highlights CVS Health, Cardinal Health, Humana and ACADIA Pharmaceuticals"
              },
              {
                "id": 141035283,
                "url": "https://finnhub.io/api/news?id=c9a7eade8b87a571ebf279bc11fef15776dcd6b21517b45c5e1c1b8d631aee38",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CI's Q2 earnings are likely to face pressure from fewer insured medical customers and a higher MCR despite expected revenue growth.",
                "category": "company",
                "datetime": 1785169980,
                "headline": "Will Declining Medical Customers Affect Cigna's Q2 Earnings?"
              },
              {
                "id": 141035247,
                "url": "https://finnhub.io/api/news?id=3ce6310c5a7787015ebdff11b4a2487d30095a481eeaf725620e2ed8721805d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS, CAH, HUM and ACAD look ready for Q2 2026 earnings beats as growing demand for medical products and services continues to support performance.",
                "category": "company",
                "datetime": 1785168180,
                "headline": "4 Medical Stocks With the Right Setup for Q2 Earnings Beats"
              },
              {
                "id": 141033957,
                "url": "https://finnhub.io/api/news?id=f9c77f2c7a2b30fa8a6e2c19700b09a28d1482789e3ac5a2c0c0cc32cff09d93",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "A steadily shrinking share count and a giant float owed to suppliers are handing owners a bigger slice of the drug distributor each year, even as drug-pricing worries hang over the stock.",
                "category": "company",
                "datetime": 1785160469,
                "headline": "The Buyback Machine Hiding Behind Cardinal Health's Thin Margins"
              },
              {
                "id": 141033965,
                "url": "https://finnhub.io/api/news?id=5d7090a4fb695f255effb47da586d72dcf54b4a024ad6a80984d2819806eaa0c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "MiniMed expands Flex access to Medicare beneficiaries, widening availability of its app-controlled pump and automated insulin delivery technology.",
                "category": "company",
                "datetime": 1785158640,
                "headline": "MMED Gets Medicare Coverage for Flex and Broadens Diabetes Care Access"
              },
              {
                "id": 141033952,
                "url": "https://finnhub.io/api/news?id=e1356cc922d24b2065e4fc35f5b4985c2626ea5c847c8e830a021f485c0ba596",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "SYK heads into Q2 with robotic surgery momentum, deferred revenue recovery and strong procedure demand as investors watch for earnings and margin trends.",
                "category": "company",
                "datetime": 1785157260,
                "headline": "Stryker's Q2 Results Likely to Reflect Recovery of Q1 Deferred Orders"
              },
              {
                "id": 141034153,
                "url": "https://finnhub.io/api/news?id=532c7af3118765071404809a553b30f6930cf4ea41667acd78881b6672af0c67",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "DXCM's Q2 results may reflect strong G7 15 Day adoption, broader reimbursement, and expanding CGM demand as investors watch for continued double-digit revenue growth.",
                "category": "company",
                "datetime": 1785157200,
                "headline": "DXCM Q2 Results Likely to Reflect Strong G7 & Reimbursement Expansion"
              },
              {
                "id": 141009489,
                "url": "https://finnhub.io/api/news?id=e8ead56a4735e9ffc71c3db2d320d99fe8efb6a9ee65c2fd5ac7ddfc1def6ef0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "ECL's Q2 results are likely to benefit from strong growth engines and pricing gains, but elevated input costs may test margins and earnings momentum.",
                "category": "company",
                "datetime": 1784913360,
                "headline": "Ecolab Gears Up to Report Q2 Results: How to Play the Stock?"
              },
              {
                "id": 141008022,
                "url": "https://finnhub.io/api/news?id=11f0b2223c504f705e7758c211d6947530f534883151cb699142f88e69716261",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "GE HealthCare heads into Q2 earnings season with solid revenue drivers, but inflation and tariff costs may keep margins under pressure before an expected second-half recovery.",
                "category": "company",
                "datetime": 1784906640,
                "headline": "Can GE HealthCare Sustain Growth in Q2 Amid Persistent Cost Headwinds?"
              },
              {
                "id": 141008023,
                "url": "https://finnhub.io/api/news?id=f8f30bf84e1e15f6f6e57395b4c780f642075ee558f77c259033ceff89883108",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "BAX's second-quarter results may reflect pressured earnings and sales as manufacturing inefficiencies, inflation, and product holds offset steady demand across segments.",
                "category": "company",
                "datetime": 1784906460,
                "headline": "Will Baxter's Q2 Results Continue to Reflect Operational Headwinds?"
              },
              {
                "id": 141010295,
                "url": "https://finnhub.io/api/news?id=4a5f786f5c2a16aec9237fc743c0601fa9f8494b3bc8026f8e392545ae8eac1b",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Citigroup  analyst Daniel Grosslight   maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $245 to $265.",
                "category": "company",
                "datetime": 1784906415,
                "headline": "Citigroup Maintains Buy on Cardinal Health, Raises Price Target to $265"
              },
              {
                "id": 141007920,
                "url": "https://finnhub.io/api/news?id=87f8d85494584027365a3886769e86bfba2dbfdaab5bcc5ff6b64728ff179ba8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "COR's specialty expansion, supply-chain investments and international momentum support growth, though pricing, debt and regulation pose risks.",
                "category": "company",
                "datetime": 1784905740,
                "headline": "Here's Why You Should Add Cencora Stock to Your Portfolio Now"
              },
              {
                "id": 141007921,
                "url": "https://finnhub.io/api/news?id=81d9e34fdfd7a95dd140c3b55594eacb4f418e518b7d324ee8d3ea4ef365f1e6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "RVTY's T-SPOT A201 targets a 2027 launch, promising high-throughput latent TB testing with greater lab efficiency and scalability.",
                "category": "company",
                "datetime": 1784905500,
                "headline": "Revvity Develops High-Throughput T-SPOT.TB Platform for Clinical Labs"
              },
              {
                "id": 141006590,
                "url": "https://finnhub.io/api/news?id=b9d1dbac7b295758ca6240d77ce744fd68e68aaf1579f112a00365686f982e57",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "SOLV's innovation, cost savings and strong segment demand support growth, while raw material cost increases remain a key risk.",
                "category": "company",
                "datetime": 1784901600,
                "headline": "Here's Why You Should Hold Solventum Stock in Your Portfolio for Now"
              },
              {
                "id": 141003274,
                "url": "https://finnhub.io/api/news?id=b6399435ea83b76f1dff5f39ca28b0dde0b387998a31199e413f65395ebe7d52",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Earlier this week, Cardinal Health announced agreements to acquire AdaptHealth's Diabetes Health business and Strive Medical for about US$360 million in cash, aiming to expand its at-Home Solutions footprint in diabetes management and urology. These moves, combined with management’s previously raised profit guidance and a history of earnings outperformance, highlight Cardinal Health’s push to deepen its role in home-based care while emphasizing cost efficiency. Now we’ll examine how Cardinal...",
                "category": "company",
                "datetime": 1784877435,
                "headline": "Do Cardinal Health’s New Home-Health Deals Reshape the Bull Case for CAH?"
              },
              {
                "id": 140997834,
                "url": "https://finnhub.io/api/news?id=8b5562ccad08c40b36749e0aaa7782b3c5636767b2c337583a15476bb8c73561",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "WST tops Q2 earnings and revenue estimates, lifts its 2026 EPS outlook and sees shares surge as high-value products fuel strong growth.",
                "category": "company",
                "datetime": 1784830080,
                "headline": "WST Stock Jumps on Q2 Earnings & Sales Beat, EPS View Up on HVP Growth"
              },
              {
                "id": 140997924,
                "url": "https://finnhub.io/api/news?id=c608774f8f6aaf6348c7b29c9bed00d94e9b347c5e5957dac96e10936ea0836d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "QDEL's strong portfolio, cost-saving progress and mixed first-quarter results support growth, though respiratory reliance remains a risk.",
                "category": "company",
                "datetime": 1784827980,
                "headline": "Reasons to Add QuidelOrtho Stock in Your Portfolio for Now"
              },
              {
                "id": 140997925,
                "url": "https://finnhub.io/api/news?id=6bec2c14e0d73dedc4197d0c596b947fcead06678116ed6826e141f2ca4addf9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "SNN expands ASC Solutions with an integrated platform, analytics and partners to boost efficiency, growth and patient outcomes in outpatient care.",
                "category": "company",
                "datetime": 1784827620,
                "headline": "Smith+Nephew Expands ASC Platform to Support Value-Based Care"
              },
              {
                "id": 140997926,
                "url": "https://finnhub.io/api/news?id=82f5bd3150e1e8a592860033e378ef16e3e71e49827df4657245156df2d5c779",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "UHS heads into Q2 with higher admissions and revenue growth expected, but rising labor and operating costs may limit earnings upside.",
                "category": "company",
                "datetime": 1784825040,
                "headline": "Can Acute Care Strength Offset Universal Health's Rising Q2 Costs?"
              },
              {
                "id": 140997927,
                "url": "https://finnhub.io/api/news?id=68be10255c11549211d68a39b771f136b909b37f137f465234c6a8b5d1ac0697",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "OPKO Health's growth outlook rests on RAYALDEE, BioReference gains and partnerships, though losses and pipeline risks persist.",
                "category": "company",
                "datetime": 1784823660,
                "headline": "Here's Why You Should Retain OPK Stock in Your Portfolio for Now"
              },
              {
                "id": 140997797,
                "url": "https://finnhub.io/api/news?id=3cbb38d923198032baed48e5d05dc6047f885315cb8b30cb7e2d44f8a571886d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CNMD's FDA-expanded AirSeal indication adds da Vinci 5 hex cannula compatibility, supporting broader use across Intuitive Surgical's robotic systems.",
                "category": "company",
                "datetime": 1784823060,
                "headline": "CONMED Expands AirSeal Robotic Solution for da Vinci 5 Hex Cannula"
              },
              {
                "id": 141010296,
                "url": "https://finnhub.io/api/news?id=3fd4f32ce46bcab2a288abc97891d3464988d9574bfe61b88378add672f99c6e",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Mizuho  analyst Steven Valiquette   maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $235 to $240.",
                "category": "company",
                "datetime": 1784813023,
                "headline": "Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $240"
              },
              {
                "id": 140993539,
                "url": "https://finnhub.io/api/news?id=d04390a2f5d1a2ac12c0498d11018ae4d58fdbbed2027ac4d48b1ecb9c06efa1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "West Pharmaceutical (WST) delivered earnings and revenue surprises of +13.94% and +4.24%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1784805304,
                "headline": "West Pharmaceutical Services (WST) Q2 Earnings and Revenues Top Estimates"
              },
              {
                "id": 140994921,
                "url": "https://finnhub.io/api/news?id=a98e6b0a0eaf99c2b60a5a3d3bdf912507cdb74f26aaa3e063c13c21cc6fbd59",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health will release its fourth-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.",
                "category": "company",
                "datetime": 1784799518,
                "headline": "Here's What to Expect From Cardinal Health's Next Earnings Report"
              },
              {
                "id": 140984919,
                "url": "https://finnhub.io/api/news?id=0441267e55f97ee798e15ff361d070bf1c8ed9dc01745bc7ba5ff30f934d5764",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CAH is set to buy two home-care businesses for about $360 million, expanding diabetes and urology reach while targeting first-year EPS accretion.",
                "category": "company",
                "datetime": 1784737140,
                "headline": "Cardinal Health Expands Home Care Business With Two Acquisitions"
              },
              {
                "id": 140984920,
                "url": "https://finnhub.io/api/news?id=baf18e37cd128514c37b8ec0c38c1918eac8f805b29c5b540d025957786c2803",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "RVTY's Signals for Startups gives early-stage biotechs scalable software and guided onboarding to streamline research and support future growth.",
                "category": "company",
                "datetime": 1784732640,
                "headline": "Revvity to Launch Signals for Startups for Emerging Biotech Companies"
              },
              {
                "id": 140983283,
                "url": "https://finnhub.io/api/news?id=7eef2f0ef94a310b7162f7e55cd6c983fa6afdabc8f241d4a68361586063a7be",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
                "category": "company",
                "datetime": 1784727604,
                "headline": "Should Value Investors Buy Cardinal Health (CAH) Stock?"
              },
              {
                "id": 140981112,
                "url": "https://finnhub.io/api/news?id=4fc8f7191cac2b2f3f86171e5b4ff55bdb0c15596d5d0c81db60975f79be44d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.",
                "category": "company",
                "datetime": 1784714787,
                "headline": "2 Unpopular Stocks That Deserve Some Love and 1 We Turn Down"
              },
              {
                "id": 140978874,
                "url": "https://finnhub.io/api/news?id=783a5049009416e464f1383e47e60174f6f4857d26efb6e5b36639e3bd66769f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health is back in focus as analysts adjust their price targets, with some raising expectations into the mid US$260s to mid US$270s and others trimming targets by single or double digit amounts. These shifts are tied to refreshed earnings models on the bullish side and more cautious views on earnings and margin assumptions on the bearish side, leaving a wide range of opinions on how the stock should be valued. Read on to see how to interpret these changing targets and keep up with the...",
                "category": "company",
                "datetime": 1784690373,
                "headline": "Cardinal Health (CAH) Stock Draws Fresh Price Target Split After Analyst Revisions"
              },
              {
                "id": 140973537,
                "url": "https://finnhub.io/api/news?id=0c072517ceb7964c6344ce4c4a6e1db55f5d2833aaccb9fecbfa046579ea7778",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal’s acquisitions of Strive Medical and Adapt Health’s diabetes unit are collectively intended to support its at-home care business’s growth strategy.",
                "category": "company",
                "datetime": 1784650549,
                "headline": "Cardinal Health makes acquisition duo worth $360m for home care business advance"
              },
              {
                "id": 140973538,
                "url": "https://finnhub.io/api/news?id=76af9a8bf8e2849af662800ca1b3cd05f6380ad54f3412b8ccb29b5da1d3e9e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "THC's Q2 performance is likely to have witnessed lower patient days, but higher revenue per admission and Ambulatory Care growth could help offset the pressure.",
                "category": "company",
                "datetime": 1784648640,
                "headline": "Will Lower Patient Days Affect Tenet Healthcare's Q2 Earnings?"
              },
              {
                "id": 140973539,
                "url": "https://finnhub.io/api/news?id=fc59b28a72e9fb67c5de58ff9b6deef6c4e9908ebb0d5136f53ed8bdb8d7d728",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "WST heads into Q2 earnings with expectations for revenue and EPS growth, backed by demand for biologics and GLP-1 components plus manufacturing gains.",
                "category": "company",
                "datetime": 1784647920,
                "headline": "WST Likely to Beat Q2 Earnings Estimates: How to Play the Stock?"
              },
              {
                "id": 140971931,
                "url": "https://finnhub.io/api/news?id=893e8bb7b41a606d4a508201130b3480b11bfd298966a40792889fd1dd974627",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "GE HealthCare's MIM Anyware offers secure browser-based imaging access to streamline workflows, collaboration and clinical decision-making.",
                "category": "company",
                "datetime": 1784645280,
                "headline": "GEHC Launches MIM Anyware for Secure Remote Imaging Collaboration"
              },
              {
                "id": 140971932,
                "url": "https://finnhub.io/api/news?id=9dc23add3d9ada15715d94fd16e1187e4c495068461106dad986a374174d4076",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "The company agreed to buy a diabetes health business and medical supplier Strive Medical to boost its growing in-home solutions unit.",
                "category": "company",
                "datetime": 1784623612,
                "headline": "Cardinal inks 2 acquisitions in bid to expand at-home services"
              },
              {
                "id": 140966299,
                "url": "https://finnhub.io/api/news?id=01d27d6c081eae89d09fc7f0851542d156690188ad124e2161d8c9fa08a6f84e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) reached $225.75 at the closing of the latest trading day, reflecting a -1.21% change compared to its last close.",
                "category": "company",
                "datetime": 1784584803,
                "headline": "Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note"
              },
              {
                "id": 140965034,
                "url": "https://finnhub.io/api/news?id=6556a2f7a1f3daf093ea745b2d90be0bcb4bafc556ac6a47297c7ea4eaf8efa0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE: CAH) announced today it has entered into two definitive agreements that accelerate its at-Home Solutions' growth strategy.",
                "category": "company",
                "datetime": 1784580300,
                "headline": "Cardinal Health expands home care business with two tuck-in acquisitions"
              },
              {
                "id": 140965035,
                "url": "https://finnhub.io/api/news?id=8ed0d2ad28580fb26c63d8fe709fbdd6958c7659c07e591f560e1f43eb772b3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CONSHOHOCKEN, Pa., July 20, 2026--AdaptHealth Corp. (NASDAQ: AHCO) (\"AdaptHealth\" or the \"Company\"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that it is divesting its Diabetes Health business to Cardinal Health.",
                "category": "company",
                "datetime": 1784579400,
                "headline": "AdaptHealth Corp. Enters into Definitive Agreement to Divest Diabetes Health Business to Cardinal Health"
              },
              {
                "id": 140964561,
                "url": "https://finnhub.io/api/news?id=83ee53e90ed8e0942706b81bbdbf93d7db62ef947ae5e72eb97caff81ae785b1",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ:AHCO), and, in its entirety, Strive Medical, a multi-specialty supply provider with a focus on urology. Combined, the transactions",
                "category": "company",
                "datetime": 1784566064,
                "headline": "Cardinal Health To Acquire The Diabetes Health Business Of Adapthealth And, In Its Entirety, Strive Medical For ~$360M In Cash"
              },
              {
                "id": 140964562,
                "url": "https://finnhub.io/api/news?id=15dcbc13b14b566fd710405edbb0e31ee1407a64b45f61607fb058eac689837d",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Continues the Company&#39;s multi-year effort to focus its portfolio on its core sleep, respiratory, and supporting home medical equipment businessesSharpens strategic focus on businesses where the Company crosses the",
                "category": "company",
                "datetime": 1784565116,
                "headline": "AdaptHealth Divests Diabetes Health Business To Cardinal Health For $235M In Cash"
              },
              {
                "id": 140962261,
                "url": "https://finnhub.io/api/news?id=d1491913f71bc313ab8a352ccc02b142e871292111d7c0dac9b0483f878506cd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "HCA faces Q2 earnings uncertainty as rising expenses and fewer outpatient surgeries may offset admission growth.",
                "category": "company",
                "datetime": 1784563980,
                "headline": "Will Higher Expenses Impact HCA Healthcare's Q2 Earnings?"
              },
              {
                "id": 140964563,
                "url": "https://finnhub.io/api/news?id=ba152ef37361b35766e43d27f97daec5c52fc4174eff439a919d1f0d8e21b6d5",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "UBS  analyst Kevin Caliendo   maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $260 to $274.",
                "category": "company",
                "datetime": 1784558481,
                "headline": "UBS Maintains Buy on Cardinal Health, Raises Price Target to $274"
              },
              {
                "id": 140960847,
                "url": "https://finnhub.io/api/news?id=81a8003193de79a3dbfb4e8aa9044d29e2a2203770ac8a44b4e0a51c3b594d32",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "BLCO launches EyeGility in the United States, pairing preloaded enVista Aspire lenses with smoother handling, one-handed use and surgical flexibility.",
                "category": "company",
                "datetime": 1784555640,
                "headline": "Bausch + Lomb Launches EyeGility Inserter for enVista IOLs in the U.S."
              },
              {
                "id": 140936423,
                "url": "https://finnhub.io/api/news?id=8ca875368ce28e82d6155decc4435d9497d091af67c722269c1c88289c31709c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "DOCS is ramping up AI across physician workflows and enterprise tools, but weak pharma ads and higher AI spending may test near-term growth.",
                "category": "company",
                "datetime": 1784312520,
                "headline": "Reasons to Retain Doximity Stock in Your Portfolio for Now"
              },
              {
                "id": 140936382,
                "url": "https://finnhub.io/api/news?id=c26d40ae96cad9381ff95484e035c0a112d0fbb5f231d9ab1d18d1ffceb82dfc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "ISRG beats second-quarter earnings and revenue estimates, but shares fall after hours as procedure growth slows sequentially despite strong placements.",
                "category": "company",
                "datetime": 1784312400,
                "headline": "ISRG Q2 Earnings Beat Estimates, Stock Falls on Slow Procedure Growth"
              },
              {
                "id": 140934568,
                "url": "https://finnhub.io/api/news?id=fcdbb1523ac61c565eff444a9974ae081ef0444ebc3b4e416bbf2d2d7408ab7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "SYK launches Mako RPS, expanding into handheld robotics for total knee replacement and broadening access to robotic-assisted orthopedic procedures.",
                "category": "company",
                "datetime": 1784302740,
                "headline": "Stryker Launches Mako RPS to Expand Robotic Knee Surgery Portfolio"
              },
              {
                "id": 140933172,
                "url": "https://finnhub.io/api/news?id=584d2c6e82fe4caccaa31dd276f5f01a46c4f00e0bf9305af59a41c44c6ee4d2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Inspire Medical's Inspire V rollout, broader approvals and clinical evidence support growth despite coding and reimbursement pressures.",
                "category": "company",
                "datetime": 1784299800,
                "headline": "Here's Why You Should Retain INSP Stock in Your Portfolio for Now"
              },
              {
                "id": 140933173,
                "url": "https://finnhub.io/api/news?id=fcfa156e27e5810bf40de392501c5b6b2e61189ff1e10b7810bc19e884395769",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "MOH faces lower Marketplace revenues and membership ahead of Q2 results, while Medicaid and Medicare premium growth may offset some pressure.",
                "category": "company",
                "datetime": 1784299440,
                "headline": "Will Declining Membership Affect Molina Healthcare's Q2 Earnings?"
              },
              {
                "id": 140933174,
                "url": "https://finnhub.io/api/news?id=38f4dc886f6f5743ddce9ccc18ddb6b253fbb91f98948f8770e782ace9535fed",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "GE HealthCare's shares rise about 4% after unveiling a $500M, 10-year alliance to deploy 1,300 technologies across Catholic Health.",
                "category": "company",
                "datetime": 1784298360,
                "headline": "GEHC Stock Up on $500M Strategic Care Alliance With Catholic Health"
              },
              {
                "id": 140924596,
                "url": "https://finnhub.io/api/news?id=d24a77b7980551d08549763d7ae3cb2c3a4883b982bad7c58ab0cf036f848548",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cooper Companies' premium contact lenses, restructuring gains and product launches support growth despite regional and competitive headwinds.",
                "category": "company",
                "datetime": 1784220840,
                "headline": "Reasons to Retain Cooper Companies Stock in Your Portfolio for Now"
              },
              {
                "id": 140922761,
                "url": "https://finnhub.io/api/news?id=5c8b91a10f59cacf4ca9e21f467d05259ae902f69ce878fc4970cd452cbb654f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Community Health heads into Q2 earnings with mixed operating trends as stronger occupancy meets lower admissions and a smaller hospital portfolio.",
                "category": "company",
                "datetime": 1784220780,
                "headline": "Can Higher Occupancy Offset Lower Admissions in CYH's Q2 Earnings?"
              },
              {
                "id": 140922763,
                "url": "https://finnhub.io/api/news?id=dc4955263ecd30f9602dfc000f5bacd34f86464174631084d5e636d601f094f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "DHR heads into Q2 earnings with bioprocessing and diagnostics strength, but rising costs and debt could pressure profitability.",
                "category": "company",
                "datetime": 1784216760,
                "headline": "Danaher Gears Up to Post Q2 Earnings: Is a Beat in the Offing?"
              },
              {
                "id": 140922823,
                "url": "https://finnhub.io/api/news?id=f0358eb2ef38cfac55cb710d83ab902a12899b63ff195ca18087e10e8ab46459",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "SNN launches the LYNX COBLATION Laryngeal Wand, combining precise dissection, rapid debulking and hemostasis for airway procedures.",
                "category": "company",
                "datetime": 1784216460,
                "headline": "Smith+Nephew Launches LYNX COBLATION Wand for ENT Airway Surgery"
              },
              {
                "id": 140921221,
                "url": "https://finnhub.io/api/news?id=04cbc645f2a607054a9a97c3eafb4c1331d516813e8454f214b2e67053e84ce3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 results despite data security risks.",
                "category": "company",
                "datetime": 1784212500,
                "headline": "Reasons to Hold HealthEquity Stock in Your Portfolio for Now"
              },
              {
                "id": 140921222,
                "url": "https://finnhub.io/api/news?id=760e9c1c7d69df2359d6c692b681a4463b5c079b953e5eeac0dbaa9ba9811f44",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "GUTS' shares surge after Revita patients retain up to 84% of GLP-1-induced weight loss in a year, compared with 46% for sham patients.",
                "category": "company",
                "datetime": 1784211180,
                "headline": "Fractyl Health Stock Up on Encouraging One-Year Revita Study Results"
              },
              {
                "id": 140911503,
                "url": "https://finnhub.io/api/news?id=908a23ff1f0b5b57234053413e27a0b4eb754eefe15823bc8c1f0f9ad0380c6f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "West Pharmaceutical is riding on strong HVP demand, GLP-1 growth and Annex 1 adoption, but can these tailwinds outweigh capacity and concentration risks?",
                "category": "company",
                "datetime": 1784131560,
                "headline": "Reasons to Add West Pharmaceutical Stock to Your Portfolio Now"
              },
              {
                "id": 140909892,
                "url": "https://finnhub.io/api/news?id=4c0aee8ff9ef958a5fe5cc75e951d08aabf5abc02060b4cccaabe752b70a9a40",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "ANGO's Q4 FY26 revenues rise 8% as Med Tech surges, while its adjusted loss beats estimates and FY27 sales guidance tops consensus.",
                "category": "company",
                "datetime": 1784125740,
                "headline": "AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands"
              },
              {
                "id": 140909893,
                "url": "https://finnhub.io/api/news?id=2bfd112b99c9ec3d18c09c29045b6009dd3dda4c7f8f478a9cb09ccd225bb69b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "NPCE's RNS adoption, referral growth and AI innovation support expansion, while IGE timing and investments may pressure near-term profits.",
                "category": "company",
                "datetime": 1784125380,
                "headline": "Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now"
              },
              {
                "id": 140909894,
                "url": "https://finnhub.io/api/news?id=5f4a27d23414e1bdf4b2eb1d42435dc1bc39ac051ca7eab04eb773d42fc9a2b3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "VEEV's strong Q1, growing Vault CRM migrations and AI expansion support growth, though life sciences CRM market saturation poses risks.",
                "category": "company",
                "datetime": 1784120640,
                "headline": "Reasons to Hold Veeva Systems Stock in Your Portfolio for Now"
              },
              {
                "id": 140909895,
                "url": "https://finnhub.io/api/news?id=46345a98de08da41fa031ab46e797686326f9cd0769b7b49d99546bed55b740d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AVTR's shares jump nearly 7% as NuSil expands its HIV prevention partnership for a three-month dapivirine vaginal ring.",
                "category": "company",
                "datetime": 1784120460,
                "headline": "Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership"
              },
              {
                "id": 140908375,
                "url": "https://finnhub.io/api/news?id=f4ed62597339749c83f097a34940712bf56323e909a7559924a9e9e18e26238e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "TMO readies for second-quarter 2026 earnings, with growth expected across key segments as bioproduction, clinical research and new launches support results.",
                "category": "company",
                "datetime": 1784119560,
                "headline": "Thermo Fisher Set to Report Q2 Earnings: What's in the Cards?"
              },
              {
                "id": 140905328,
                "url": "https://finnhub.io/api/news?id=1498bdd648988741dec00616509e87d01f6f00131e3d3d26db699d8e7350d89c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health’s recent performance and growth drivers Cardinal Health (CAH) has attracted fresh attention after entering the second half of 2026 with momentum tied to broad pharmaceutical demand and faster growth in its specialty businesses. For investors, the key question is how durable these drivers might prove. Specialty pharmaceuticals sit at the center of this story, with Cardinal Health benefiting from demand for oncology therapies, GLP-1 products, and branded medicines. Recent...",
                "category": "company",
                "datetime": 1784081397,
                "headline": "Is Cardinal Health (CAH) Still Undervalued As Specialty Growth Lifts Expectations?"
              },
              {
                "id": 140904333,
                "url": "https://finnhub.io/api/news?id=0b64755bd48b71f6c1a8155c9a0f7dba2208fe96790993d8d7e183c57505fef8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In the closing of the recent trading day, Cardinal Health (CAH) stood at $230.11, denoting a -1.52% move from the preceding trading day.",
                "category": "company",
                "datetime": 1784066402,
                "headline": "Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why"
              },
              {
                "id": 140898373,
                "url": "https://finnhub.io/api/news?id=7f5bdde751f9c35aa6159ecbf69ebd1e7c98ab35526de50e323e5694daee49eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "DexCom's G7 15 Day wins Health Canada authorization, offering longer wear, high accuracy and smart features for adults with diabetes.",
                "category": "company",
                "datetime": 1784038800,
                "headline": "DXCM Secures Health Canada Authorization for Dexcom G7 15 Day CGM"
              },
              {
                "id": 140897140,
                "url": "https://finnhub.io/api/news?id=17b1a1c2cd8f1e4d82fd54c4e45c19b1481a4408b625cd8b02959bdf27ace66c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health stock has delivered a very strong 5 year run, yet the current valuation checks lean expensive, which raises the question of how much of that strength is already reflected in the price. The share price has returned about 365.1% over 5 years, which places recent gains in the context of a long period of strong compounding. Recent news highlights growth momentum in higher margin specialty pharmaceuticals and chronic care, while competitive and regulatory pressures remain an...",
                "category": "company",
                "datetime": 1784035219,
                "headline": "Cardinal Health (CAH) Stock Looks Overvalued Following Fresh Earnings Beat Hopes"
              },
              {
                "id": 140895339,
                "url": "https://finnhub.io/api/news?id=c1c02517fb2d6062636fc20fa28984d3617d173e198049742585adea5db0ca27",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outlook article.",
                "category": "company",
                "datetime": 1784014260,
                "headline": "Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry"
              },
              {
                "id": 140890118,
                "url": "https://finnhub.io/api/news?id=2d67f1cbe12d9df8211cfc8bae473d12b523f08edb98312468848a3f2b0237d7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "ELV faces Q2 pressure as weaker Health Benefits results and higher benefit expenses may weigh on earnings ahead of its July 15 report.",
                "category": "company",
                "datetime": 1783966080,
                "headline": "Will Health Benefits Weakness Drag Elevance's Q2 Earnings?"
              },
              {
                "id": 140888586,
                "url": "https://finnhub.io/api/news?id=02c32f4236530d9c3c8408db3b26474a8bed1445de7e9b3af2fa2a9fcebd5ba0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.",
                "category": "company",
                "datetime": 1783961101,
                "headline": "Looking for a Growth Stock? 3 Reasons Why Cardinal (CAH) is a Solid Choice"
              },
              {
                "id": 140888587,
                "url": "https://finnhub.io/api/news?id=23fd34574599028cd6535e7a4f359605d176c869633009b46055b092da4d12f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here, we highlight five dental supplies stocks, MCK, CAH, WST, ALGN and HSIC, which are well positioned to generate wealth for investors amid improving industry prospect.",
                "category": "company",
                "datetime": 1783960560,
                "headline": "5 Medical Supply Stocks to Buy Amid Strong Industry Tailwinds"
              },
              {
                "id": 140888588,
                "url": "https://finnhub.io/api/news?id=6b1d5a7ae5e4207e8a8614cd2954d3fa23c977d91e49e1e4a198995ffbf0ba43",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
                "category": "company",
                "datetime": 1783959003,
                "headline": "Why Cardinal (CAH) is Poised to Beat Earnings Estimates Again"
              },
              {
                "id": 140887112,
                "url": "https://finnhub.io/api/news?id=0f04adeb023c5b19c5040c5712ccad327b737146e55e34c0fd0eb52164c77616",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here is how argenex SE (ARGX) and Cardinal Health (CAH) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1783950004,
                "headline": "Are Medical Stocks Lagging  Argenx (ARGX) This Year?"
              },
              {
                "id": 140866137,
                "url": "https://finnhub.io/api/news?id=3f13457ebf4a4219407fc1e247b73e139d9eff63c7d44cc4326643ba6b21d03b",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the latest list here.",
                "category": "company",
                "datetime": 1783706132,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of July 12"
              },
              {
                "id": 140863166,
                "url": "https://finnhub.io/api/news?id=e946794061ef07309da8a11ae69a8862df0fff20c00259ff44cede14df1fa8a2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "The average brokerage recommendation (ABR) for Cardinal (CAH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",
                "category": "company",
                "datetime": 1783690203,
                "headline": "Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest?"
              },
              {
                "id": 140854823,
                "url": "https://finnhub.io/api/news?id=458be9d1a0c21e9ffb0379eda2cd0d33d1c708842673ec4aae2c1304cd927346",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CAH's Russell index removal reflects reclassification after its share rally, while specialty growth and resilient operations continue supporting its long-term outlook.",
                "category": "company",
                "datetime": 1783621260,
                "headline": "Should You Retain CAH Stock After Removal From Several Russell Indices?"
              },
              {
                "id": 140851015,
                "url": "https://finnhub.io/api/news?id=80cb5ec78359f04f857bbd8be1ca3f1da0e6c2e01ae8595ae0acef02466d10d9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "While the market debates growth, this healthcare giant is steadily retiring its own shares, a strategy that has quietly compounded value for investors.",
                "category": "company",
                "datetime": 1783603475,
                "headline": "McKesson Stock Is Shrinking, and That's The Point for Owners"
              },
              {
                "id": 140853648,
                "url": "https://finnhub.io/api/news?id=b2d05548698b403d1523232e7d03e840810070ba29e7cfbb57b5b9e02c77c856",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "TD Cowen  analyst Charles Rhyee   maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $255 to $275.",
                "category": "company",
                "datetime": 1783599877,
                "headline": "TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $275"
              },
              {
                "id": 140850071,
                "url": "https://finnhub.io/api/news?id=de200de5ce1b21a0426a5352101b175508fdd6c749c77d1606f6c11f30c60029",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2026 on August 11, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.",
                "category": "company",
                "datetime": 1783593900,
                "headline": "Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2026 on August 11"
              },
              {
                "id": 140846416,
                "url": "https://finnhub.io/api/news?id=4d1ac8d3b07142e4e7e2fd6ddf2a31d3ec0e9057b634a2c9561f03335dac0dec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) concluded the recent trading session at $237.15, signifying a -1.07% move from its prior day's close.",
                "category": "company",
                "datetime": 1783548903,
                "headline": "Cardinal Health (CAH) Declines More Than Market: Some Information for Investors"
              },
              {
                "id": 140844540,
                "url": "https://finnhub.io/api/news?id=461ed182f4f549cdfa263d6a928aea7f3d04659f55a2bb0153bb938bd4603612",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "While the market debates the future of drug pricing, this healthcare giant is steadily handing a larger piece of the business back to its owners.",
                "category": "company",
                "datetime": 1783535061,
                "headline": "McKesson Stock Is Shrinking, And That's The Point"
              },
              {
                "id": 140842566,
                "url": "https://finnhub.io/api/news?id=0302ac2b2ac358fb031e0e7752080a8d220ecc3485e7bb3c6c0fd7cee8712075",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2227733246/image_2227733246.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "McKesson is a stable portfolio holding with regular moderate growth amid a challenging, overvalued market environment. Read more on MCK stock here.",
                "category": "company",
                "datetime": 1783516359,
                "headline": "McKesson Checks All The Boxes To Survive And Prosper In A Weak Economy, But There's A Big Catch"
              },
              {
                "id": 140835507,
                "url": "https://finnhub.io/api/news?id=1ff4aac3f9d633edc4fe2b43d1c25618d747701c819628733167f2c6c3ec7211",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In late June 2026, Cardinal Health, Inc. was removed from the Russell 1000 Defensive, Russell 1000 Growth-Defensive, and Russell 1000 Value-Defensive indices, even as it reported quarterly revenue of US$60.94 billion and net profit of US$399 million. At the same time, upbeat commentary from Jim Cramer and reaffirmed positive analyst views highlighted Cardinal Health’s reputation as a healthcare sector stalwart despite its index reclassifications. Next, we’ll examine how this combination of...",
                "category": "company",
                "datetime": 1783459063,
                "headline": "Does Index Removal Amid Solid Results Change The Bull Case For Cardinal Health (CAH)?"
              },
              {
                "id": 140842604,
                "url": "https://finnhub.io/api/news?id=25b9737c32659b118e6d06e5fd552407615007fb05e58b3082830c3625d38b4e",
                "image": "https://image.cnbcfm.com/api/v1/image/108331765-3ED1-MM-A-070726.jpg?v=1783463497&w=1920&h=1080",
                "source": "CNBC",
                "related": "CAH",
                "summary": "CNBC's Jim Cramer discusses the day's market action, the stocks he's watching and more.",
                "category": "company",
                "datetime": 1783451536,
                "headline": "I find it surprising that so much money was flowing into the hyperscalers: Cramer"
              },
              {
                "id": 140822441,
                "url": "https://finnhub.io/api/news?id=a8a1b28066f6e208b8e9c7195cc557e003be78ce757401f35ac4df52844cd88e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.",
                "category": "company",
                "datetime": 1783358941,
                "headline": "Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?"
              },
              {
                "id": 140807781,
                "url": "https://finnhub.io/api/news?id=7d52d19d05cda671822fdd3b1227333a17707b003b922bd120c0f38bcdee2052",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health, Inc. (NYSE:CAH) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer said that the stock deserves to “trade higher,” as he commented: Can I call your attention to what may be the best one in this group? I’m talking about […]",
                "category": "company",
                "datetime": 1783174848,
                "headline": "Jim Cramer on Cardinal Health: “It’s Been a Real Stalwart, and I Don’t Think It’s Done”"
              },
              {
                "id": 140801970,
                "url": "https://finnhub.io/api/news?id=8d6fb7d50212e52acef49fd4cca54e09d0c6c76b24dd5b4a0917e964b5baf046",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1886168190/image_1886168190.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Cardinal Health receives a Buy rating, supported by defensive business fundamentals and strong adjusted EPS growth. Read more on CAH stock here.",
                "category": "company",
                "datetime": 1783090514,
                "headline": "Cardinal Health: Why This Essential Healthcare Distributor Deserves A Buy Rating"
              },
              {
                "id": 140793341,
                "url": "https://finnhub.io/api/news?id=7751c4204569198b12c51f40c3f0ddd3f71d55fcc2e968637c26a0615101294c",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "B of A Securities  analyst Allen Lutz   maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $240 to $260.",
                "category": "company",
                "datetime": 1782990015,
                "headline": "B of A Securities Maintains Buy on Cardinal Health, Raises Price Target to $260"
              },
              {
                "id": 140792257,
                "url": "https://finnhub.io/api/news?id=c695286d7754a1888990f708cd63bc406a376127bc2185825e118715ea2c95c2",
                "image": "https://image.cnbcfm.com/api/v1/image/108329650-4ED3-MM-A-BLOCK-070126.jpg?v=1782947054&w=1920&h=1080",
                "source": "CNBC",
                "related": "CAH",
                "summary": "CNBC's Jim Cramer discusses the day's market action, the stocks he's watching and more.",
                "category": "company",
                "datetime": 1782933515,
                "headline": "Meta's new cloud business will be instantly profitable, says Jim Cramer"
              },
              {
                "id": 140780871,
                "url": "https://finnhub.io/api/news?id=af5080e11481be0b1b046a88ccbc555298fda3756f3f9b31ba119c574a829518",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
                "category": "company",
                "datetime": 1782913203,
                "headline": "Are Investors Undervaluing Cardinal Health (CAH) Right Now?"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 4,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 102,
            "discarded_article_count": 85
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17.3,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.4,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.4,
            "vcp_reason": "站上MA50；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 2402283.3333333335,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 2029770,
              "avg_vol_20": 2297215,
              "avg_vol_30": 2402283.3333333335,
              "range_pct_10": 0.06008188740701614,
              "range_pct_20": 0.10053263788018842,
              "range_pct_30": 0.10449407984506366,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.8449336395235089,
              "dist_to_20d_high": 0.06586904050536412,
              "down_shrink_days": 2,
              "breakout_level_20d": 243.21001,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.574978864794075
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 1.6,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.18381090717021,
              "turnoverUsdM": 449.82461331,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.CAH",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 217.2672,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 2.5,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 4.4,
            "take_profit_price": 238.5495,
            "target_multiplier": 1.9,
            "technical_strength": 1.68,
            "take_profit_percent": 5
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.36762181434042,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 4.9614,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.18
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -70.58
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.147
    },
    "kdj": {
      "d": 51.63,
      "j": 70.46,
      "k": 57.91,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 46.85
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 19394751,
      "recentSlope": -30124.9,
      "previousSlope": -952480
    },
    "rsi": 39.94,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 221.1733,
      "position": "SAR喺價下",
      "distancePct": 2.65,
      "previousTrend": "上升"
    },
    "ma50": 221.0988,
    "macd": {
      "macd": 1.1408175842798869,
      "trend": "中性偏多",
      "signal": 2.0678523682871,
      "histogram": -0.9270347840072133
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 231.6401,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.85,
      "score": 4,
      "avgVolume": 2327727,
      "currentVolume": 1979949
    },
    "derived": {
      "ma20": 230.72,
      "ma50": 221.0988,
      "prevClose": 229.12,
      "avgVolume10": 1966985,
      "avgVolume20": 2327727,
      "changePercent": -0.84,
      "avgVolumeForScore": 2327727
    },
    "ma_cross": {
      "ma20": 230.72,
      "ma50": 221.0988,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 231.2465,
      "prevMa50": 220.5504,
      "spreadPct": 4.35,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 220.5843,
      "upper": 240.8557,
      "position": "中間"
    },
    "rsi_short": 69.23,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.85
    }
  }
}

Raw metrics JSON

{
  "close": 227.19,
  "volume": 1979949,
  "changePercent": -0.84
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.

US.CAH · Cardinal Health

避免

Score and price trend

Summary

Rolling setup rating

Has the score quality changed?

Signals

Full calculation detail

Market inputs

Metrics snapshot

110-point main rating

基本面 — 2.8/5 · 較差

Sub-items

資金流 — 9.2/20 · 較差

Sub-items

institutional

details

warning

市場環境 — 6.4/15 · 較差

Sub-items

vix

details

trend

details

qqq

spy

催化劑 — 2/20 · 較差

Sub-items

catalyst

details

風險管理 — 7.4/10 · 良好

Sub-items

position

details

stopLevels

strength_details

diversification

details

技術信號 — 17.3/30 · 較差

Sub-items

vcpPayload

vcp_metrics

情緒分析 — 6/10 · 一般

Sub-items

sentiment

details

sentimentData

Dimension contribution

5D momentum v2 breakdown

Risk management

position

details

stopLevels

strength_details

diversification

details

Calculation audit log

Technical indicators

Raw calculation JSON

Raw metrics JSON